US20160291029A1 - Novel Fluorescent Dyes, Labeled Conjugates and Analytical Methods - Google Patents
Novel Fluorescent Dyes, Labeled Conjugates and Analytical Methods Download PDFInfo
- Publication number
- US20160291029A1 US20160291029A1 US15/187,543 US201615187543A US2016291029A1 US 20160291029 A1 US20160291029 A1 US 20160291029A1 US 201615187543 A US201615187543 A US 201615187543A US 2016291029 A1 US2016291029 A1 US 2016291029A1
- Authority
- US
- United States
- Prior art keywords
- radical
- alkyl
- carbon atoms
- group
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000007850 fluorescent dye Substances 0.000 title abstract description 22
- 238000004458 analytical method Methods 0.000 title description 3
- 125000001072 heteroaryl group Chemical group 0.000 claims description 31
- 150000001875 compounds Chemical class 0.000 claims description 29
- 125000003118 aryl group Chemical group 0.000 claims description 27
- 125000004432 carbon atom Chemical group C* 0.000 claims description 25
- 229910052739 hydrogen Inorganic materials 0.000 claims description 21
- 239000001257 hydrogen Substances 0.000 claims description 21
- 125000000217 alkyl group Chemical group 0.000 claims description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 238000003556 assay Methods 0.000 claims description 18
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 18
- 229920000642 polymer Polymers 0.000 claims description 17
- 125000005647 linker group Chemical group 0.000 claims description 14
- 150000001413 amino acids Chemical class 0.000 claims description 12
- 229910052799 carbon Inorganic materials 0.000 claims description 12
- 108020004707 nucleic acids Proteins 0.000 claims description 12
- 150000007523 nucleic acids Chemical class 0.000 claims description 12
- 102000039446 nucleic acids Human genes 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 11
- 125000003729 nucleotide group Chemical group 0.000 claims description 11
- 125000006575 electron-withdrawing group Chemical group 0.000 claims description 10
- 239000002773 nucleotide Substances 0.000 claims description 10
- 238000012546 transfer Methods 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 125000006239 protecting group Chemical group 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229910052717 sulfur Inorganic materials 0.000 claims description 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 5
- 125000003435 aroyl group Chemical group 0.000 claims description 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 5
- 239000003053 toxin Substances 0.000 claims description 5
- 231100000765 toxin Toxicity 0.000 claims description 5
- 125000002252 acyl group Chemical group 0.000 claims description 4
- 239000013060 biological fluid Substances 0.000 claims description 4
- 239000002777 nucleoside Substances 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 239000011593 sulfur Chemical group 0.000 claims description 4
- 150000003833 nucleoside derivatives Chemical class 0.000 claims description 3
- YSBUWGJBGQCVAY-UHFFFAOYSA-N 3-(4-chlorophenyl)-5-fluoro-2h-isoquinolin-1-one Chemical compound FC1=CC=CC(C(N2)=O)=C1C=C2C1=CC=C(Cl)C=C1 YSBUWGJBGQCVAY-UHFFFAOYSA-N 0.000 claims description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical group [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 2
- 150000001450 anions Chemical class 0.000 claims description 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 2
- 125000002837 carbocyclic group Chemical group 0.000 claims description 2
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 229910052711 selenium Inorganic materials 0.000 claims description 2
- 239000011669 selenium Chemical group 0.000 claims description 2
- 150000002431 hydrogen Chemical group 0.000 claims 7
- 125000003473 lipid group Chemical group 0.000 claims 1
- 239000000975 dye Substances 0.000 abstract description 40
- 238000005462 in vivo assay Methods 0.000 abstract description 2
- -1 benzothiazoles Chemical class 0.000 description 47
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 27
- 102000004190 Enzymes Human genes 0.000 description 22
- 108090000790 Enzymes Proteins 0.000 description 21
- 239000000126 substance Substances 0.000 description 20
- 125000001424 substituent group Chemical group 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 239000000758 substrate Substances 0.000 description 12
- 229910019142 PO4 Inorganic materials 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 235000021317 phosphate Nutrition 0.000 description 10
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- 230000005855 radiation Effects 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 8
- 238000003384 imaging method Methods 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 239000010452 phosphate Substances 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 0 CC.[1*]C1=C([2*])[2H]=C([3*])C([Y])=C1C1=NC2=CC=CC=C2C1 Chemical compound CC.[1*]C1=C([2*])[2H]=C([3*])C([Y])=C1C1=NC2=CC=CC=C2C1 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
- 238000006303 photolysis reaction Methods 0.000 description 6
- 230000015843 photosynthesis, light reaction Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 125000006413 ring segment Chemical group 0.000 description 6
- 206010056740 Genital discharge Diseases 0.000 description 5
- 125000003545 alkoxy group Chemical group 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- 230000003595 spectral effect Effects 0.000 description 5
- YEDUAINPPJYDJZ-UHFFFAOYSA-N 2-hydroxybenzothiazole Chemical class C1=CC=C2SC(O)=NC2=C1 YEDUAINPPJYDJZ-UHFFFAOYSA-N 0.000 description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000002738 chelating agent Substances 0.000 description 4
- 125000000623 heterocyclic group Chemical group 0.000 description 4
- 125000000592 heterocycloalkyl group Chemical group 0.000 description 4
- 239000002207 metabolite Substances 0.000 description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 125000003107 substituted aryl group Chemical group 0.000 description 4
- 150000003573 thiols Chemical class 0.000 description 4
- 108700012359 toxins Proteins 0.000 description 4
- 239000001226 triphosphate Substances 0.000 description 4
- 235000011178 triphosphate Nutrition 0.000 description 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 3
- XXJGBENTLXFVFI-UHFFFAOYSA-N 1-amino-methylene Chemical compound N[CH2] XXJGBENTLXFVFI-UHFFFAOYSA-N 0.000 description 3
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 3
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 3
- MBVFRSJFKMJRHA-UHFFFAOYSA-N 4-fluoro-1-benzofuran-7-carbaldehyde Chemical compound FC1=CC=C(C=O)C2=C1C=CO2 MBVFRSJFKMJRHA-UHFFFAOYSA-N 0.000 description 3
- 108090001008 Avidin Proteins 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 3
- 108090001090 Lectins Proteins 0.000 description 3
- 102000004856 Lectins Human genes 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 229910006074 SO2NH2 Inorganic materials 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 108010090804 Streptavidin Proteins 0.000 description 3
- 125000004442 acylamino group Chemical group 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 3
- 125000003282 alkyl amino group Chemical group 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 125000001769 aryl amino group Chemical group 0.000 description 3
- 125000005110 aryl thio group Chemical group 0.000 description 3
- 125000004104 aryloxy group Chemical group 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- 150000003857 carboxamides Chemical class 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 150000003983 crown ethers Chemical class 0.000 description 3
- 125000004663 dialkyl amino group Chemical group 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 125000001188 haloalkyl group Chemical group 0.000 description 3
- 125000005843 halogen group Chemical group 0.000 description 3
- 125000005241 heteroarylamino group Chemical group 0.000 description 3
- 125000005553 heteroaryloxy group Chemical group 0.000 description 3
- 125000005368 heteroarylthio group Chemical group 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 230000005865 ionizing radiation Effects 0.000 description 3
- 239000002523 lectin Substances 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 125000004092 methylthiomethyl group Chemical group [H]C([H])([H])SC([H])([H])* 0.000 description 3
- 230000000269 nucleophilic effect Effects 0.000 description 3
- 125000000538 pentafluorophenyl group Chemical group FC1=C(F)C(F)=C(*)C(F)=C1F 0.000 description 3
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 3
- 125000000565 sulfonamide group Chemical group 0.000 description 3
- 125000005309 thioalkoxy group Chemical group 0.000 description 3
- 125000003396 thiol group Chemical class [H]S* 0.000 description 3
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 description 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 2
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 2
- 150000000183 1,3-benzoxazoles Chemical class 0.000 description 2
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical compound C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 description 2
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 2
- VHMICKWLTGFITH-UHFFFAOYSA-N 2H-isoindole Chemical compound C1=CC=CC2=CNC=C21 VHMICKWLTGFITH-UHFFFAOYSA-N 0.000 description 2
- GHKBFOCIKCBJFU-UHFFFAOYSA-N 3-hydroxy-4-(1H-indol-2-yl)benzonitrile Chemical compound OC1=C(C=CC(=C1)C#N)C=1NC2=C(C=1)C=CC=C2 GHKBFOCIKCBJFU-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000014654 Adna Species 0.000 description 2
- 241000796533 Arna Species 0.000 description 2
- FTEDXVNDVHYDQW-UHFFFAOYSA-N BAPTA Chemical compound OC(=O)CN(CC(O)=O)C1=CC=CC=C1OCCOC1=CC=CC=C1N(CC(O)=O)CC(O)=O FTEDXVNDVHYDQW-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- DQWWIWJHNKHTEQ-UHFFFAOYSA-N CC.CC1=NC2=CC=CC=C2C1 Chemical compound CC.CC1=NC2=CC=CC=C2C1 DQWWIWJHNKHTEQ-UHFFFAOYSA-N 0.000 description 2
- QDQNDBFCSSAFMN-UHFFFAOYSA-N CC1=NC=CCO1.CC1=NCCO1 Chemical compound CC1=NC=CCO1.CC1=NCCO1 QDQNDBFCSSAFMN-UHFFFAOYSA-N 0.000 description 2
- WNRAFEVYHLEPJW-UHFFFAOYSA-N CCOC(=N)C1=CC([Y])=C(C2=NC3=C(C=CC=C3)C2)C=C1 Chemical compound CCOC(=N)C1=CC([Y])=C(C2=NC3=C(C=CC=C3)C2)C=C1 WNRAFEVYHLEPJW-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- 102000053187 Glucuronidase Human genes 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 101710120037 Toxin CcdB Proteins 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 125000003368 amide group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 150000001448 anilines Chemical class 0.000 description 2
- 210000004102 animal cell Anatomy 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 102000005936 beta-Galactosidase Human genes 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 102000006995 beta-Glucosidase Human genes 0.000 description 2
- 108010047754 beta-Glucosidase Proteins 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000012875 competitive assay Methods 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 238000002059 diagnostic imaging Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical class O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 238000002060 fluorescence correlation spectroscopy Methods 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000013198 immunometric assay Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011503 in vivo imaging Methods 0.000 description 2
- 125000003387 indolinyl group Chemical class N1(CCC2=CC=CC=C12)* 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 150000002540 isothiocyanates Chemical class 0.000 description 2
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 230000005291 magnetic effect Effects 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 229920000137 polyphosphoric acid Chemical group 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 150000003212 purines Chemical class 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000006862 quantum yield reaction Methods 0.000 description 2
- 150000003248 quinolines Chemical class 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
- APJYDQYYACXCRM-UHFFFAOYSA-N tryptamine Chemical compound C1=CC=C2C(CCN)=CNC2=C1 APJYDQYYACXCRM-UHFFFAOYSA-N 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- NFNLOQYKMLSTRT-UHFFFAOYSA-N 1,10-phenanthroline;pyridine Chemical compound C1=CC=NC=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 NFNLOQYKMLSTRT-UHFFFAOYSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- QORVGJAHBMMXFG-UHFFFAOYSA-N 2,2,6-triaminohexanoic acid Chemical compound NCCCCC(N)(N)C(O)=O QORVGJAHBMMXFG-UHFFFAOYSA-N 0.000 description 1
- KBUVFXFAMAADHJ-UHFFFAOYSA-N 2-(1h-indol-2-yl)-9h-carbazole Chemical class C1=C2NC3=CC=CC=C3C2=CC=C1C1=CC2=CC=CC=C2N1 KBUVFXFAMAADHJ-UHFFFAOYSA-N 0.000 description 1
- PIINGYXNCHTJTF-UHFFFAOYSA-N 2-(2-azaniumylethylamino)acetate Chemical group NCCNCC(O)=O PIINGYXNCHTJTF-UHFFFAOYSA-N 0.000 description 1
- IXZONVAEGFOVSF-UHFFFAOYSA-N 2-(5'-chloro-2'-phosphoryloxyphenyl)-6-chloro-4-(3H)-quinazolinone Chemical compound OP(O)(=O)OC1=CC=C(Cl)C=C1C1=NC(=O)C2=CC(Cl)=CC=C2N1 IXZONVAEGFOVSF-UHFFFAOYSA-N 0.000 description 1
- JOFSHTFUEFBHHJ-UHFFFAOYSA-N 2-[2-(carboxymethoxy)-n-(carboxymethyl)anilino]acetic acid Chemical class OC(=O)COC1=CC=CC=C1N(CC(O)=O)CC(O)=O JOFSHTFUEFBHHJ-UHFFFAOYSA-N 0.000 description 1
- VVVVLXDNHVULMF-UHFFFAOYSA-N 2-dibenzofuran-2-yl-1h-indole Chemical class C1=CC=C2C3=CC(C4=CC5=CC=CC=C5N4)=CC=C3OC2=C1 VVVVLXDNHVULMF-UHFFFAOYSA-N 0.000 description 1
- HBOANDSCGBDDFC-UHFFFAOYSA-N 2-dibenzothiophen-2-yl-1H-indole Chemical class N1C(=CC2=C1C=CC=C2)C1=CC2=C(SC3=C2C=CC=C3)C=C1 HBOANDSCGBDDFC-UHFFFAOYSA-N 0.000 description 1
- 239000001903 2-oxo-3-phenylpropanoic acid Substances 0.000 description 1
- MXNVEJDRXSFZQB-UHFFFAOYSA-N 3-hydroxyquinoline-4-carboxylic acid Chemical compound C1=CC=C2C(C(=O)O)=C(O)C=NC2=C1 MXNVEJDRXSFZQB-UHFFFAOYSA-N 0.000 description 1
- RESKSOIIHUXLOJ-UHFFFAOYSA-N 4-cyano-2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(C#N)C=C1O RESKSOIIHUXLOJ-UHFFFAOYSA-N 0.000 description 1
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 1
- SXTSBZBQQRIYCU-UHFFFAOYSA-N 4-guanidinobenzoic acid Chemical class NC(=N)NC1=CC=C(C(O)=O)C=C1 SXTSBZBQQRIYCU-UHFFFAOYSA-N 0.000 description 1
- 208000035657 Abasia Diseases 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 101710195183 Alpha-bungarotoxin Proteins 0.000 description 1
- 108090000531 Amidohydrolases Proteins 0.000 description 1
- 102000004092 Amidohydrolases Human genes 0.000 description 1
- 108091029845 Aminoallyl nucleotide Proteins 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- FDBLKVJRBBQULK-PBWIUFEOSA-L C.CCOC(=N)C1=CC(OP(=O)(O)O)=C(C2=NC3=[Y]C=CC=C3C2)C=C1.CCOC(=N)C1=CC(OP(=O)(O[Na])[Na]O)=C(C2=NC3=[Y]C=CC=C3C2)C=C1.CCOP(=O)(Cl)OCC.CCOP(=O)(OCC)OC1=C(C2=NC3=[Y]C=CC=C3C2)C=CC(C#N)=C1.C[Si](C)(C)Br.Cl.N#CC1=CC(O)=C(C2=NC3=[Y]C=CC=C3C2)C=C1.N#CC1=CC(OP(=O)(O)O)=C(C2=NC3=[Y]C=CC=C3C2)C=C1.O[Na] Chemical compound C.CCOC(=N)C1=CC(OP(=O)(O)O)=C(C2=NC3=[Y]C=CC=C3C2)C=C1.CCOC(=N)C1=CC(OP(=O)(O[Na])[Na]O)=C(C2=NC3=[Y]C=CC=C3C2)C=C1.CCOP(=O)(Cl)OCC.CCOP(=O)(OCC)OC1=C(C2=NC3=[Y]C=CC=C3C2)C=CC(C#N)=C1.C[Si](C)(C)Br.Cl.N#CC1=CC(O)=C(C2=NC3=[Y]C=CC=C3C2)C=C1.N#CC1=CC(OP(=O)(O)O)=C(C2=NC3=[Y]C=CC=C3C2)C=C1.O[Na] FDBLKVJRBBQULK-PBWIUFEOSA-L 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- WXNWYGMHZTVMCY-UHFFFAOYSA-N CC1=CC=C(C)O1.CC1=CN=C(C)O1.CC1=NCC(C)O1.CC1=NNC(C)C1 Chemical compound CC1=CC=C(C)O1.CC1=CN=C(C)O1.CC1=NCC(C)O1.CC1=NNC(C)C1 WXNWYGMHZTVMCY-UHFFFAOYSA-N 0.000 description 1
- JKPSNBMVMVSIOE-UHFFFAOYSA-N CC1=CC=CC=C1N.O=COC1=C(O)C=NC2=C1C=CC=C2.OC1=C(C2=NC3=CC=CC=C3C2)C2=C(C=CC=C2)N=C1 Chemical compound CC1=CC=CC=C1N.O=COC1=C(O)C=NC2=C1C=CC=C2.OC1=C(C2=NC3=CC=CC=C3C2)C2=C(C=CC=C2)N=C1 JKPSNBMVMVSIOE-UHFFFAOYSA-N 0.000 description 1
- ZFMIXIOTBABLTO-UHFFFAOYSA-N CCOC(=N)C1=CC(OP(=O)(O)O)=C(C2=NC3=C(C=CC=C3)O2)C=C1.CCOC(=N)C1=CC(OP(=O)(O)O)=C(C2=NC3=C(C=CC=C3)S2)C=C1.CCOC(=N)C1=CC(OP(=O)(O)O)=C(C2=NC3=C(C=CC=N3)O2)C=C1 Chemical compound CCOC(=N)C1=CC(OP(=O)(O)O)=C(C2=NC3=C(C=CC=C3)O2)C=C1.CCOC(=N)C1=CC(OP(=O)(O)O)=C(C2=NC3=C(C=CC=C3)S2)C=C1.CCOC(=N)C1=CC(OP(=O)(O)O)=C(C2=NC3=C(C=CC=N3)O2)C=C1 ZFMIXIOTBABLTO-UHFFFAOYSA-N 0.000 description 1
- ZMOGHKFKXHUFHJ-UHFFFAOYSA-N CCOC(=N)C1=CC([Y])=C(C2C=C3C=CN(C)C=C3N2)C=C1 Chemical compound CCOC(=N)C1=CC([Y])=C(C2C=C3C=CN(C)C=C3N2)C=C1 ZMOGHKFKXHUFHJ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical compound NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 1
- 101710091342 Chemotactic peptide Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 108010065556 Drug Receptors Proteins 0.000 description 1
- 102000002045 Endothelin Human genes 0.000 description 1
- 108050009340 Endothelin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000008072 Lymphokines Human genes 0.000 description 1
- 108010074338 Lymphokines Proteins 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 108090000189 Neuropeptides Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 229910018828 PO3H2 Inorganic materials 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 229910006069 SO3H Inorganic materials 0.000 description 1
- 102000005262 Sulfatase Human genes 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- BTKMJKKKZATLBU-UHFFFAOYSA-N [2-(1,3-benzothiazol-2-yl)-1,3-benzothiazol-6-yl] dihydrogen phosphate Chemical compound C1=CC=C2SC(C3=NC4=CC=C(C=C4S3)OP(O)(=O)O)=NC2=C1 BTKMJKKKZATLBU-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical class C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- DEDGUGJNLNLJSR-UHFFFAOYSA-N alpha-hydroxycinnamic acid Natural products OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001745 anti-biotin effect Effects 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 150000004074 biphenyls Chemical class 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000003271 compound fluorescence assay Methods 0.000 description 1
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 125000000332 coumarinyl group Chemical class O1C(=O)C(=CC2=CC=CC=C12)* 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000005292 diamagnetic effect Effects 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 239000005546 dideoxynucleotide Substances 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- CQBWPUJYGMSGDU-UHFFFAOYSA-N ethyl benzenecarboximidate Chemical compound CCOC(=N)C1=CC=CC=C1 CQBWPUJYGMSGDU-UHFFFAOYSA-N 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005206 flow analysis Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 150000008195 galaktosides Chemical class 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229930182480 glucuronide Natural products 0.000 description 1
- 150000008134 glucuronides Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 108010022683 guanidinobenzoate esterase Proteins 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 150000002443 hydroxylamines Chemical class 0.000 description 1
- 150000002463 imidates Chemical class 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 125000004628 isothiazolidinyl group Chemical group S1N(CCC1)* 0.000 description 1
- 125000003965 isoxazolidinyl group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000002796 luminescence method Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- XLTANAWLDBYGFU-UHFFFAOYSA-N methyllycaconitine hydrochloride Natural products C1CC(OC)C2(C3C4OC)C5CC(C(C6)OC)C(OC)C5C6(O)C4(O)C2N(CC)CC31COC(=O)C1=CC=CC=C1N1C(=O)CC(C)C1=O XLTANAWLDBYGFU-UHFFFAOYSA-N 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 229930013053 morphinan alkaloid Natural products 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- UPSFMJHZUCSEHU-JYGUBCOQSA-N n-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4r,5r,6s)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](NC(C)=O)[C@H](OC=2C=C3OC(=O)C=C(C)C3=CC=2)O[C@@H]1CO UPSFMJHZUCSEHU-JYGUBCOQSA-N 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 150000002843 nonmetals Chemical class 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 125000000160 oxazolidinyl group Chemical group 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 108010045867 phallotoxin Proteins 0.000 description 1
- 150000005053 phenanthridines Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 108060006184 phycobiliprotein Proteins 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 150000003246 quinazolines Chemical class 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 239000000985 reactive dye Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- HSSLDCABUXLXKM-UHFFFAOYSA-N resorufin Chemical compound C1=CC(=O)C=C2OC3=CC(O)=CC=C3N=C21 HSSLDCABUXLXKM-UHFFFAOYSA-N 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 150000003958 selenols Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 108060007951 sulfatase Proteins 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 125000001273 sulfonato group Chemical class [O-]S(*)(=O)=O 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- BZWKPZBXAMTXNQ-UHFFFAOYSA-N sulfurocyanidic acid Chemical compound OS(=O)(=O)C#N BZWKPZBXAMTXNQ-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000001984 thiazolidinyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 238000005891 transamination reaction Methods 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 125000006168 tricyclic group Chemical group 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 238000000827 velocimetry Methods 0.000 description 1
- 210000000605 viral structure Anatomy 0.000 description 1
- 238000003135 vital staining of organelle Methods 0.000 description 1
- LYTCVQQGCSNFJU-LKGYBJPKSA-N α-bungarotoxin Chemical compound C(/[C@H]1O[C@H]2C[C@H]3O[C@@H](CC(=C)C=O)C[C@H](O)[C@]3(C)O[C@@H]2C[C@@H]1O[C@@H]1C2)=C/C[C@]1(C)O[C@H]1[C@@]2(C)O[C@]2(C)CC[C@@H]3O[C@@H]4C[C@]5(C)O[C@@H]6C(C)=CC(=O)O[C@H]6C[C@H]5O[C@H]4C[C@@H](C)[C@H]3O[C@H]2C1 LYTCVQQGCSNFJU-LKGYBJPKSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
- C07F9/65324—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B69/00—Dyes not provided for by a single group of this subclass
- C09B69/007—Dyestuffs containing phosphonic or phosphinic acid groups and derivatives
Definitions
- aspects of the invention are directed to novel dye compounds and, more particularly, to novel dye compounds which are useful as fluorescent reporters for use in diagnostic assays, and to labeled conjugates and diagnostic and in vivo assays utilizing the compounds and conjugates.
- chemiluminescence refers to the transient emission of light during an enzymatic reaction. Fluorescence is the emission of longer wavelength (visible region) of light by a molecule when excited by shorter wavelength (usually in the UV region) of light. If the luminescence is generated by an enzyme, an extra level of amplification is added to the system.
- chemiluminescence is often regarded as the most sensitive signal system, fluorescence has certain advantages over chemiluminescence.
- a chemiluminescent molecule can decay only once, giving a single photon, while a fluorophore is continuously excited, having the capacity to emit tens of thousands photons before losing fluorescence due to chemical degradation or photobleaching.
- Other disadvantages of chemiluminescence include: laborious requirements for use, limitations on sensitivity arising from the transience of chemiluminescence itself, and, the broad spectral emission which precludes the simultaneous detection of multiple analytes in a single sample.
- fluorescence can detect single molecules either by fluorescence correlation spectroscopy or other methods.
- the extreme sensitivity potential is limited by interfering signals (noise). These signals may originate from biological components, plastics, reagent impurities, light scattering from particles, background light (“stray” light) which exists in all fluorescence detectors because of the light source used to induce excitation, contamination from a variety of sources, poor aqueous solubility of fluorogenic molecules, significant photoquenching and poor photostability in aqueous solutions and low turnover rates of available fluorogenic substrates by their specific enzymes.
- a fluorescent molecule can be derivatized so that it can be used either (i) to covalently attach as a fluorescent tag or (ii) as a “fluorogenic” enzyme substrate which can be converted by the action of an enzyme specific for that substrate, into a fluorescent product which exhibits greatly enhanced fluorescence as compared to the starting substrate.
- the rate or extent to which a substrate for that enzyme has been converted into a detectable chemiluminescent or fluorogenic final product is used to detect or measure the activity of the enzyme.
- an enzyme In biological assays, the activity of an enzyme is used to indirectly detect or measure the quantity of a complementary biological “target”.
- Hydrolytic enzymes such as alkaline phosphatase, ⁇ -galactosidase, ⁇ -glucuronidase and ⁇ -glucosidase have been widely used in conjunction with fluorogenic substrates. These enzymes act on substrate molecules which have been derivatized at hydroxyl moieties to create phosphoric acid, galactoside, glucuronide and glucoside substrates, respectively, and the parent fluorescent molecule.
- Derivatives of fluorescein, ATTOPHOS® dyes, and BODIPY® dyes are some of the commercially available dyes for this purpose.
- U.S. Pat. No. 5,443,986 (Haughland et al.)discloses detecting the activity of enzymes and enzyme conjugates using substrates made from a class of fluorophores generally including quinazolines, benzimidazoles, benzothiazoles,benzoxazoles, quinolines, indolines and phenanthradines.
- 2-benzazole fluors possess unusually strong, UV stimulated, proton transfer fluorescence in the visible spectral region, having a fluorescence emission peak at about 520 nm or longer at room temperature or above room temperature. These compounds also exhibit fluorescence quantum yields of 0.5 or greater at 300° K.
- HBT 2-(2′-hydroxyphenyl) benzothiazole
- novel fluorescent dyes which are represented by Formula I
- D is selected from —C—R 5 , —C-(A) q-R 6 , E + (G ⁇ ), and
- X is selected from oxygen, sulfur, selenium, N—B, and —C ( ⁇ O) O—;
- B is selected from hydrogen, alkyl having from 1 to 10 carbon atoms, aryl, heteroaryl, acyl, aroyl having from 1 to 10 carbon atoms and heteroaroyl having from 1 to 10 carbon atoms);
- Z is carbon or nitrogen
- Z a is selected from carbon, nitrogen and —C-(A)q-R 6 ;
- Z b is selected from carbon, N-alkyl and N-aryl
- A is a divalent linking group having alternating single and multiple bonds such as, for example, —CH ⁇ CH—, —C ⁇ C—, CH ⁇ CH—CH ⁇ CH—, —C ⁇ C—C ⁇ C—, —CH ⁇ CH—C ⁇ C—, —C ⁇ C—CH ⁇ CH— and the like; or a combination of multiple bonds conjugated with an unsaturated ring system which may be aromatic or heteroaromatic such as, for example,
- E + is oxygen or N + —R 7 , where R 7 is hydrogen, cyano, alkyl, linear or branched, preferably having from 1 to 10 carbon atoms, arylalkyl, preferably having from 1 to 10 carbon atoms or heteroarylalkyl, preferably having from 1 to 10 carbon atoms;
- (G ⁇ ) is any suitable counterion such as, for example, chloride, cyano, sulfate, sulfonate, trifluoroacetate, phosphate, hexafluorophosphate, tetrafluoroborate, etc.;
- Y is a proton transfer group; such as, for example, —OH, NH 2 , —NHSO 2 Ar, —NHSO 2 OH, —NHC( ⁇ O)Ar, —NHC( ⁇ O)OH, —O(PG),
- Ar is an aromatic or a heteroaromatic moiety
- PG is a protective group
- R 1 , R 2 and R 3 each independently is selected from hydrogen, an electron withdrawing group and an electron releasing group; or
- R 1 and R 2 taken together with the carbon atoms to which they are attached represent the carbon atoms necessary to form a substituted or unsubstituted unsaturated carbocycic or heteroaromatic ring;
- R 4 is selected from hydrogen, an electron withdrawing group and an electron releasing group
- R 5 is selected from hydrogen and a 5 or 6 member aromatic or heteroaromatic ring such as, for example, 4-cyanophenyl or 4-quinolyl, or R 2 and R 5 taken together with the carbon atoms to which they are attached represent the carbon atoms necessary to form an unsaturated carbocyclic or heteroaromatic ring system such as, for example, a 7,7-disubstituted-7H-indeno[2,1-quinoline ring or a 9.9-disubstituted-9H-fluorene ring;
- R 11 is hydrogen, alkyl, aryl, heteroaryl, H 2 W or R 13 R 14 ;
- R 12 is hydrogen, alkyl, aryl or heteroaryl
- R 13 is hydrogen
- R 11 and R 12 taken together with the nitrogen and oxygen atoms to which they are attached represent the carbon atoms necessary to form a substituted or unsubstituted, saturated or unsaturated ring as shown in the examples below.
- R 14 is alkyl, aryl or heteroaryl
- W is any suitable anion such as a halide or a sulfate n is an integer of from 0 to 4; and q is 0 or 1, provided that at least Z a or D is —C-(A) q-R 6 .
- Typical suitable electron releasing groups which are suitable for R 1 , R 2 , R 3 and R 4 include linear or branched chain alkyl (C 1 -C 10 ), methoxy, hydroxyl, amino, (C 1 -C 10 alkyl) amino, (C 1 -C 10 dialkyl)amino, (C 1 -C 10 acyl) amido, (C 1 -C 10 aroyl) amido, (C 1 -C 10 acyl) oxy, (C 1 -C 10 aroyl) oxy, aryl and halogens.
- Typical electron withdrawing groups which are suitable for R 1 , R 2 , R 3 and R 4 include nitrile, nitro, R 8 —C( ⁇ O), (R 8 ⁇ C l -C 10 ).
- —C( ⁇ O)—O—R 8 —C( ⁇ O)—O—Ar 1 , —C( ⁇ O)—OH, —C( ⁇ O)—NH 2 , —C( ⁇ O)—NHR 9 , —C( ⁇ O)—NR 9 R 10 , where R 9 and R 10 are each independently alkyl or aryl;
- Typical suitable proton transfer groups include —OH, —NHSO 2 Ar, —NHSO 2 OH, —NHC( ⁇ O)Ar, —NHC( ⁇ O)OH, —O(PG). —N(PG) SO 2 Ar, —N(PG)SO 2 OH, —N(PG)C( ⁇ O)Ar, —N(PG)C( ⁇ O)OH and the like.
- Ar may be substituted with one or more electron releasing or electron withdrawing groups.
- substituents are methyl and t-butyl groups.
- Preferred proton transfer groups are those having a pKa between about 5 and about 15 or such a group in which the transferable proton has been replaced with a protective group PG.
- the proton transfer groups may be photo-cleavable groups.
- the compounds with a transferable proton are fluorescent while the compounds where this proton has been replaced with a protective group are weakly fluorescent or non-fluorescent.
- the protective group, PG. can be cleaved and a proton substituted in its place by hydrolytic enzymes or by photolysis.
- Typical suitable protective(blocking) groups for use as PG include phosphate (PO 3 H 2 ), mono and di salt anion of phosphate, mono and di salt anion of sulfate, galactose, sialic acid, glucose, glucuronic acid, amino acids, peptides or the same protected with a blocking group, lipids, nucleic acids, 4-guanidino-benzoate, alkylether derivatives and the like
- These protective groups can be cleaved by enzymes such as alkaline phosphatase, sulfatase, beta-galactosidase, neuraminidase, beta-glucosidase, beta-glucuronidase, various proteases, lipases and nucleases, guanidinobenzoatase, and microsomal dealkylases, respectively.
- enzymes such as alkaline phosphatase, sulfatase, beta-galactosidase, neuraminidase, beta-glucosidase, beta-glucuronidase, various proteases, lipases and nucleases, guanidinobenzoatase, and microsomal dealkylases, respectively.
- signal enzymes Amidases and N-dealkylases are examples of signal enzymes that can be used when Y ⁇ N(PG)SO 2 Ar or —N(PG)C( ⁇ O)Ar.
- photo-cleavable protective groups are, 2-nitrobenzyl, alpha-substituted 2-nitrobenzyl (where the alpha substituent is alkyl, aryl, alkoxy, heteroaromatic or alkenyl),2-nitrobenzyloxycarbonyl, alpha substituted 2-nitrobenzyloxycarbonyl, 3,5-dimethoxybenzyloxycarbonyl, ⁇ , ⁇ -dimethyl-3,5-dimethoxybenzyloxycarbonyl, 3-nitrophenyloxy, 3,5-dinitrophenyloxy and 6-nitroveratryloxycarbonyl. Exposure of the precursor dye to light of appropriate wavelength liberates a pulse of highly fluorescent dye.
- Y is a phosphate group (i.e. Y ⁇ —OPO3H2)
- an enzyme such as alkaline phosphatase can be used to generate the fluorescent 2-hydroxy-4-benzimidic acid ester of the benzazole of Formula I, which has large Stokes shift, high quantum efficiency and radiation and chemical stability.
- the Stokes shift and fluorescence quantum efficiency of the dyes can be modified by appropriate substitution of the benzene rings.
- the blocked or protected precursors are generally non-fluorescent or weakly fluorescent or fluoresce at substantially shorter wavelengths than those of the corresponding unprotected parent dyes. Exposure of the precursor dye to light of appropriate wavelength liberates a pulse of highly fluorescent dye. The blocked precursor can be added to a sample or sample stream and allowed to reach the target area, but only upon photolysis is the desired fluorescent parent molecule produced in the illuminated area. Following photolysis, the subsequent migration, diffusion, photobleaching, enzymatic conversion to non-fluorescent products or localization of the dye can be observed as a function of the time and location since photolysis.
- a typical blocking group used for this purpose is o-nitroarylmethine.
- the o-nitroarylmethine group Upon photolysis, the o-nitroarylmethine group is intramolecularly converted to a derivative of o-nitrosophenone. Hydroxy, amino derivatives of anthracene, naphthalenes, coumarins, fluorescein, resorufin and rhodamine have been protected using the o-nitroarylmethine group.
- photolabile groups are, 2-nitrobenzyl, alpha-substituted 2-nitrobenzyl (where the alpha substituent is alkyl, aryl, alkoxy, heteroaromatic or alkenyl), 2-nitrobenzyloxycarbonyl, alpha substituted 2-nitrobenzyloxycarbonyl, 3,5-dimethoxybenzyloxycarbonyl, ⁇ , ⁇ -dimethyl-3,5-dimethoxybenzyloxycarbonyl, 3-nitrophenyloxy, 3,5-dinitrophenyloxy and 6-nitroveratryloxycarbonyl.
- These dyes can be made water soluble by attaching hydrophilic groups such as sulfonic acid or its salts. These water soluble “caged” dyes can then be used in aqueous systems (e.g. physiological fluids) to conduct studies such as flow analysis, velocimetry, analysis of ligand-receptor interactions etc.
- Photochemically fluorogenic molecules can also be used in imaging systems.
- a benzazole of the type shown in Formula 1 protected with a photolabile group can be used in the preparation of printing plates.
- R 15 is selected from hydrogen, an electron withdrawing group and an electron releasing group
- R 16 is selected from hydrogen, an electron withdrawing group and an electron releasing group
- n 0 or 1
- o is an integer of from 0 to 4.
- E, G, X, Y, Z, Z a , Z b , R 4 , R 6 , q and n are as previously defined.
- Representative compounds of the invention are:
- the fluorophores of the invention described herein belong to the class of ESIPT fluors. These compounds have the advantages of high fluorescence quantum efficiency, large Stokes' shift and high chemical and radiation stability. These compounds have an added advantage since they exhibit intense fluorescence in aromatic hydrocarbons such as benzene and toluene.
- the fluor released by an esterase from its precursor can be extracted with toluene and its intensity measured in toluene. Since other biomolecules have negligible solubility in toluene there will be no interference due to background noise. By varying the substituents on these compounds their spectral properties can be modified.
- Plastic scintillators typically include a fluorescent molecule dissolved in a matrix material which is transparent in at least a portion of the visible electromagnetic radiation spectrum such as polystyrene and are used for the detection and measurement of ionizing radiation. Ionizing radiation, upon striking the matrix material, causes it to emit UV radiation which is absorbed by the fluorescent molecule which then emits visible radiation.
- Liquid scintillation cocktails contain a fluorescent molecule dissolved in a solvent such as toluene and other additives.
- Liquid scintillation products are used for measuring radiation emitted by biomolecules labeled with a radioisotope such as 32P (see, for example, U.S. Pat. Nos. 5,298,189; 5,552,551 and 5,587,112).
- Fluorescent dyes are widely used as tracers for localization of biological structures by fluorescence microscopy, for quantification of analytes by fluorescence immunoassay, for flow cytometric analysis of cells, for measurement of physiological state of cells, for quantification assays such as DNA sequencing, and other applications (Haugland et al., U.S. Pat. No. 5,442,045). Fluorescent dyes are also used for the determination of ions like Calcium and gases like nitric oxide The isothiocyanate derivatives of these dyes can also be used for protein/peptide sequencing by the Edman degradation procedure (see Jin, S. W. et al., FEBS Lett. 150, 198, 1986; Hirano, H. et al., Biol. Chem. Hoppe-Seyler, 1259, 367, 1980).
- labeled conjugates comprising a radical of a dye molecule of Formulas I-III and a radical of a biological/synthetic (organic, inorganic) moiety.
- These fluorescent conjugates are made by attaching chemically reactive fluorescent dyes to reactive sites on a wide variety of materials, both organic and inorganic.
- the biological/synthetic moiety may be attached at various positions on the dye moiety the preferred points of attachment are at the R 1 , R 2 and R 3 positions (Formula I) and the various substituents in Formulas II-IV.
- the attachment of the biological/synthetic moiety to the linkage through which it is attached to the dye, or to the dye, may be through any appropriate position on the biological/synthetic moiety which will not negatively affect the intended function of the biological/synthetic moiety.
- the novel conjugates of the invention include at least one biological/synthetic moiety which can be attached directly to the dye or which can be attached to the dye through a divalent achromophoric linking group.
- achromophoric linking group is meant one which does not cause any appreciable shift in the spectral absorption characteristics of the dye moiety.
- the linkage should be non-conjugated.
- the linking group may also have a chelating group.
- the selection of the covalent linkage to attach the benzazoles to the conjugated substance typically depends on the functional group on the substance to be conjugated.
- the types of functional groups typically present on the organic or inorganic substances include, but are not limited to, amines, thiols, alcohols, phenols, aldehydes, ketones, phosphates, imidazoles, hydrazines, hydroxylamines, disubstituted amines, halides, epoxides, sulfonate esters, purines, pyrimidines, carboxylic acids, or a combination of these groups.
- a single type of reactive site may be available on the substance (typical for polysaccharides), or a variety of sites may occur (e.g. amines, thiols, alcohols, phenols), as is typical for proteins. Although some selectivity can be obtained by careful control of the reaction conditions, selectivity of labeling is best obtained by selection of an appropriate reactive dye.
- Typical functional groups which are useful as coupling groups which can be attached to the dye molecule, and the substituents of the biological/synthetic moiety with which such coupling groups can be reacted to provide the achromophoric linking group within the labeled conjugate are listed in Table I.
- linking groups may be incorporated into the labeled conjugates of the invention.
- the hydrophilic groups mentioned above are substantially achromophoric and certain of these can be derivatized and utilized as suitable linking groups.
- an —NH 2 group can be converted to an amide as a result of attaching the biologically active moiety (“BIO”) to it, i.e., —NHCO-BIO.
- BIO biologically active moiety
- a hydrophilic group may be attached to the linking group.
- the linking group while serving as the means for attaching the dye moiety to the biologically active moiety, can also have a hydrophilic group attached to it.
- the linking group may also function as a hydrophilic group such as, for example, in the case of —NH,-BIO and —PO 2 (OH)-BIO.
- Solubilizing groups may also be attached to suitable positions on the dyes. The presence of such solubilizing groups can help to avoid undesirable nonspecific binding of the conjugates to components present in biological fluids such as, for example, plasma proteins.
- the fluorescent dyes and labeled fluorescent conjugates of the invention may be used in various applications including diagnostic assays which are based on an energy transfer to fluorescent label and assays which are based on enzymatic attack on the conjugate to release the fluorescent moiety, in vivo imaging applications, analytical methods, etc.
- diagnostic assays which are based on an energy transfer to fluorescent label and assays which are based on enzymatic attack on the conjugate to release the fluorescent moiety
- diagnostic assays which are based on an energy transfer to fluorescent label and assays which are based on enzymatic attack on the conjugate to release the fluorescent moiety
- diagnostic assays which are based on an energy transfer to fluorescent label and assays which are based on enzymatic attack on the conjugate to release the fluorescent moiety
- in vivo imaging applications e.g., X-ray imaging, positron emission tomography (PET), ultrasound imaging and magnetic resonance imaging (MRI)
- PET positron emission tomography
- MRI magnetic resonance imaging
- Imaging involves significant health risks to a patient when the patient is exposed to the radiation for prolonged periods of time or in multiple imaging schemes. Furthermore, certain of these imaging techniques undesirably involve the use of invasive procedures which are both costly and painful. Yet other techniques such as MRI do not yield consistently useful results. Imaging techniques involving measurement of light emitted by fluorescent molecules localized in an organ afford non-invasive, safe and relatively fast methods for selectively highlighting in vivo biological targets, biomarkers and pathways that underlie disease progression and therapeutic response. In practice the fluorescent molecules alone or the fluorescent conjugates are injected into a patient. The moiety attached to the fluorescent dye radical in the conjugate can assist in targeting the fluorescent molecule to a specific particular site. See, for example, U.S. Pat. Nos. 6,304,771 and 7,303,741.
- ligands are frequently used to confer a specificity for a biochemical reaction that is to be observed and the fluorescent dye provides the means of detection or quantitation of the reaction.
- the ligand is usually a member of activate the a pair of molecules that can bond together with a high degree of specificity. Examples of specific binding pairs are shown in Table II. Binding pair members present in animal cells, plant cells, bacteria, yeast or viruses can be detected with fluorescent probes.
- the complementary member may also be immobilized on a solid or semi-solid surface such as a polymer, polymeric membrane or polymeric particle.
- the fluorescent dye may also have a protective group PG which can be cleaved enzymatically or by photolysis after binding to the complementary member (see, for example, U.S. Pat. No. 5,696,157 to Haughland).
- aDNA and aRNA are the antisense strands used for hybridization.
- fluorescent labels for use in such assays have a relatively long emission wavelength, e.g., above 500 nm.
- the labels have a large Stokes shift, be stable under the assay conditions, be relatively free of non-specific interference both from materials in solution and the moiety to which the label is conjugated and exhibit high quantum yields.
- dyes whose fluorescence is not quenched in aqueous solutions it is desirable that have dyes whose fluorescence is not quenched in aqueous solutions.
- Useful dye-conjugates of the present invention include conjugates of biomolecules (antigens, haptens, an Fab fragment, amino acids, peptides, proteins, nucleic acids, nucleic acid polymers, carbohydrates, lipids), drugs, vitamins, metabolites, toxins, environmental pollutants, pesticides, ion-complexing moieties, cells or cellular components.
- biomolecules antigens, haptens, an Fab fragment, amino acids, peptides, proteins, nucleic acids, nucleic acid polymers, carbohydrates, lipids
- drugs vitamins, metabolites, toxins, environmental pollutants, pesticides, ion-complexing moieties, cells or cellular components.
- the conjugates of the present invention are conjugates of cells, cellular systems, cellular fragments or sub-cellular particles.
- the conjugated materials include virus particles, bacterial particles, virus components, biological cells (such as animal cells, plant cells, bacteria or yeast) or cellular components.
- the conjugated substance is an amino acid or a polymer of amino acids such as a peptide or protein.
- Amino acids mean natural amino acids or their optical isomers, as well as synthetic variations utilized in the art. Common synthetic variations include amino acids that are protected on their amino, carboxylic acid, hydroxyl, thiol, imidazole or other functional group. Other modified amino acids are substituted by phosphate, or through glycosylation or acylation with a C 1 to C 22 carboxylic acid.
- Peptides generally have molecular weights of less than about 5,000 to 10,000 daltons, and proteins have molecular weights greater than about 5,000 to 10,000 daltons and typically possess secondary, tertiary and/or quaternary structure.
- Preferred conjugates of peptides contain at least five amino acids, more preferably 5 to 36 amino acids.
- Preferred peptides to be conjugated to the dyes of the invention include, but are not limited to, neuropeptides, chemotactic peptides, cytokines (such as lymphokines), gastrointestinal peptides, toxins, protease substrates, synthetic peptides, experimental peptides, endothelin and protein kinase substrates.
- Protein conjugates of the invention include labeled enzymes, antibodies, catalytic antibodies, kinases, lectins, glycoproteins, histories, albumins, lipoproteins, avidin, streptavidin, protein A, protein G, phycobiliproteins, hormones, toxins and growth factors.
- the conjugated protein is an antibody, an antibody fragment, avidin, streptavidin, ⁇ -bungarotoxin, a lectin, a growth factor, or a phallotoxin.
- the conjugated substance is a single nucleic acid base, single nucleoside, single nucleotide or a nucleic acid polymer.
- a nucleotide comprises an ester of a nucleoside and one or more phosphoric acid or polyphosphoric acid groups, optionally containing an additional linker or spacer for attachment of a fluorophore or other ligand, such as an alkynyl linkage (U.S. Pat. No. 5,047,519 to Hobbs, Jr. et al., (1991), incorporated by reference), an aminoallyl linkage (U.S. Pat. No. 4,711,955 to Ward et al. (1987), incorporated by reference) or other linkages.
- Nucleotides include natural and synthetic derivatives, including deoxynucleotides, dideoxynucleotides, cyclonucleotides and abasic nucleotide analogs, wherein the base is replaced by a fluorophore or hapten.
- the conjugated nucleotide is a mono-, di- or triphosphate ester of an adenosine, a guanosine, a uridine, a cytidine or a thymidine. More preferably, the conjugated nucleotide is a nucleoside triphosphate or a deoxynucleoside triphosphate or a dideoxynucleoside triphosphate.
- Preferred conjugates of nucleic acid polymers are labeled oligonucleotides composed of fewer than 50 nucleotides, more typically composed of fewer than 25 nucleotides. Oligonucleotides are optionally deoxyribonucleic acid polymers (DNA) or ribonucleic acid polymers (RNA), or a hybrid thereof. Nucleic acid polymers are optionally single-stranded or multi-stranded; and may be a natural polymer (biological in origin) or a synthetic polymer (modified or prepared artificially).
- the nucleic acid polymer optionally incorporates an unusual linker such as morpholine derivatized phosphates (Antivirals, Inc., Corvallis Oregon), or peptide nucleic acids such as N-(2-aminoethyl)glycine units (Wittung, et al., NATURE 368, 561 (1994)).
- an unusual linker such as morpholine derivatized phosphates (Antivirals, Inc., Corvallis Oregon), or peptide nucleic acids such as N-(2-aminoethyl)glycine units (Wittung, et al., NATURE 368, 561 (1994)).
- the dye is attached to the nucleotide, oligonucleotide or nucleic acid polymer via one or more purine or pyrimidine bases through an amide, ester, ether or thioether bond.
- the dye is attached to the phosphate or carbohydrate by a bond that is an este
- the conjugated substance is a carbohydrate, i.e. an organic compound composed of carbon, hydrogen and oxygen and occasionally nitrogen or sulfur, that include sugars, starches and celluloses.
- the conjugated substance is typically a polysaccharide, such as dextran, FICOL, heparin, glycogen, amylopectin, mannan, inulin, starch, agarose and cellulose, all of which are readily available.
- Preferred polysaccharide conjugates are dextran or FICOL conjugates, more preferably a dextran conjugate.
- the conjugated substance is a lipid.
- Lipids are long-chain saturated or unsaturated aliphatic hydrocarbons (typically having 6-25 carbon atoms) and their derivatives, such as fatty acids, alcohols, amines, amino alcohols, and aldehydes.
- the class of lipids includes glycolipids, phospholipids and sphingolipids.
- the conjugated substance is a lipid vesicle, such as a liposome, or is a lipoprotein.
- the dye contains a lipophilic substituent, e. g. a linear saturated or unsaturated fatty alkyl group, typically with 12-18 carbon atoms.
- the conjugated substance is a drug or toxin.
- preferred drugs of interest are the alkaloids (including morphine alkaloids), steroids, lactams having from 5 to 6 annular members, aminoalkylbenzenes, benzheterocyclics, purines, marijuana-derived drugs, vitamins, prostaglandins, antibiotics and aminoglycosides, as well as their individual derivatives and metabolites. Metabolites related to diseased states include spermine, galactose, phenylpyruvic acid and porphyrin Type 1.
- pesticides of interest are polyhalogenated biphenyls, phosphate esters, thiophosphates, carbamates, polyhalogenated sulfenamides, their metabolites and derivatives.
- the conjugated substance is optionally an ion-complexing moiety.
- Preferred ion-complexing moieties are crown ether, including diaryldiaza crown ethers, as described in U.S. Pat. No. 5,405,975 to Kuhn et al. (1995); derivatives of 1,2-bis-(2-aminophenoxyethane)-N,N,N′,N′-tetraacetic acid (BAPTA), as described in U.S. Pat. No. 5,453,517 to Kuhn et al. (1995), U.S. Pat. No. 5,516,911 to London et al., and U.S. Pat. No. 5,049,673 to Tsien et al.
- conjugated ion-complexing moiety is a diaryldiaza crown ether chelator or a BAPTA chelator.
- Conjugates of non-biological polymers are also useful aspects of the invention, including dye-conjugates of synthetic polymers, polymeric particles (including magnetic and non-magnetic microparticles) polymeric membranes, conducting and non-conducting metals and non-metals, and glass and plastic surfaces and particles.
- Conjugates are optionally prepared by copolymerization of a benzazole dye that contains an appropriate functionality (for example an acrylic acid- or styryl-substituent) while preparing the polymer, or more commonly by chemical modification of a polymer that contains functional groups with suitable chemical reactivity.
- the conjugated substance is a glass or silica, which may be formed into an optical fiber or other structure.
- diagnostic assay methods including in vivo diagnostic imaging methods.
- the labeled conjugates of the invention may be used in any of many applications such as, for example, in diagnostic assays such as sandwich assays, competitive assays, immunometric assays or in immune response reactions employing labeled reagents.
- the dyes and labeled conjugates of the invention may also be used for the fluorescent staining of cells.
- the cells may then be observed under a microscope with the presence of the fluorescent molecule being indicative of the presence of a specific determinative site.
- the dyes and conjugates may be used for the deletion, separation or other application in a fluorescent activated cell sorter.
- the fluorescent dyes can also be used for vacuolar staining of yeast and other fungi (see, for example, U.S. Pat. No. 5,445,946) and Gram reaction in bacterial populations (see, for example, U.S. Pat. No. 5,545,535).
- the fluorescent dyes that are able to preferentially bind to a specific biological molecule in a sample enable the determination of the presence or quantity of that specific molecule.
- the specific cellular structures can be monitored with respect too their spatial and temporal distribution in diverse environments.
- the dyes can be used for the determination of ionic, electrical or metabolic properties of cellular organelles (see, for example, U.S. Pat. No. 5,459,268), immunofluorescence labeling, fluorescent analog cytochemistry, vital staining of organelles, assessment of cell morphology or intracellular coupling with microinjected tracers, measurement of distances between probes by fluorescence energy transfer and measurement of diffusion coefficients and exchange rates by photobleaching recovery (see, for example, Roger Y. Tsien, Ann. Rev. Neurosci. 12, 227, 1989).
- the fluorescent conjugates of organophosphorus nerve agents can be used for the screening and selection of nerve agents (Luis, Briseno-Roa et al, J. Med. Chem. 49, 246, 2006).
- aryl refers to a mono-, bicyclic or tricyclic carbocyclic ring system having one, two or three aromatic rings including, but not limited to, phenyl, naphthyl, anthryl, azulyl, tetrahydronaphthyl, indanyl, indenyl and the like.
- substituted aryl refers to an aryl group, as defined herein, substituted by independent replacement of one or more of the hydrogen atoms thereon with substituents independently selected from substituents such as, but not limited to, alkyl, haloalkyl, alkoxy, thioalkoxy, amino, alkylamino, dialkylamino, acylamino, hydroxyl, cyano, halo, mercapto, nitro, carboxaldehyde, carboxyl, alkoxycarbonyl, carboxamide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, benzyl, benzyloxy, aryloxy, heteroaryloxy, C 1 -C 6 -alkoxy, methoxymethoxy, methoxyethoxy, amino, benzylamino, arylamino, heteroarylamino, C 1 -C 3 -alkylamino, thi
- substituents include, but are not limited to, F, Cl, Br, I, OH, NO 2 , CN, C(O)—C 1 -C 6 -alkyl, C(O)-aryl, C(O)-heteroaryl, CO 2 -alkyl, CO 2 -aryl, CO 2 -heteroaryl, CONH 2 , CONH—C 1 -C 6 -alkyl, CONH-aryl, CONH-heteroaryl, OC(O)—C 1 -C 6 -alkyl, OC(O)-aryl, OC(O)-heteroaryl, OCO 2 -alkyl, OCO 2 -aryl, OCO 2 -heteroaryl, OCONH 2 , OCONH—C 1 -C 6 -alkyl, OCONH-aryl, OCONH-heteroaryl, NHC(O)—C 1 -C 6 -alkyl, NHC(O)
- heterocyclic refers to heterocycloalkyl and heteroaryl.
- substituted heterocyclic refers to substituted heterocycloalkyl and substituted heteroaryl.
- heterocycloalkyl refers to a non-aromatic 3-, 4-, 5-, 6- or 7-membered ring or a bi- or tri-cyclic group comprising fused six-membered rings having between one and three heteroatoms independently selected from oxygen, sulfur and nitrogen, wherein (i) each 5-membered ring has 0 to 1 double bonds and each 6-membered ring has 0 to 2 double bonds, (ii) the nitrogen and sulfur heteroatoms may optionally be oxidized, (iii) the nitrogen heteroatom may optionally be quaternized, and (iv) any of the above heterocyclic rings may be fused to a benzene ring.
- heterocycles include, but are not limited to, pyrrolidinyl, pyrazolinyl, pyrazolidinyl, imidazolinyl, imidazolidinyl, piperidinyl, piperazinyl, oxazolidinyl, isoxazolidinyl, morpholinyl, thiazolidinyl, isothiazolidinyl, and tetrahydrofuryl.
- substituted heterocycloalkyl refers to a cycloalkyl group, as defined herein, substituted by independent replacement of one or more of the hydrogen atoms therein with substituents independently selected from substituents such as, but not limited to, alkyl, haloalkyl, alkoxy, thioalkoxy, amino, alkylamino, dialkylamino, acylamino, hydroxyl, cyano, halo, mercapto, nitro, carboxaldehyde, carboxyl, alkoxycarbonyl, carboxamide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, benzyl, benzyloxy, aryloxy, heteroaryloxy, C 1 -C 6 alkoxy, methoxymethoxy, methoxyethoxy, amino, benzylamino, arylamino, heteroarylamino, C 1 -C 3 -alkyla
- substituents include, but are not limited to, F, Cl, Br, I, OH, NO 2 , CN, C(O)—C 1 -C 6 -alkyl, C(O)-aryl, C(O)-heteroaryl, CO 2 -alkyl, CO 2 -aryl, CO 2 -heteroaryl, CONH 2 , CONH—C 1 -C 6 -alkyl, CONH-aryl, CONH-heteroaryl, OC(O)—C 1 -C 6 -alkyl, OC(O)-aryl, OC(O)-heteroaryl, OCO 2 -alkyl, OCO 2 -aryl, OCO 2 -heteroaryl, OCONH 2 ,OCONH—C 1 -C 6 -alkyl, OCONH-aryl, OCONH-heteroaryl, NHC(O)—C 1 -C 6 -alkyl, NHC(O)
- heteroaryl refers to a cyclic aromatic radical having from five to ten ring atoms of which one ring atom is selected from S, O and N; zero, one or two ring atoms are additional heteroatoms independently selected from S, O and N; and the remaining ring atoms are carbon, the radical being joined to the rest of the molecule via any of the ring atoms, such as, for example, pyridinyl, pyrazinyl, pyrimidinyl, pyrrolyl, pyrazolyl, imidazolyl, thiazolyl, oxazolyl, isooxazolyl, thiadiazolyl, oxadiazolyl, thiophenyl, furanyl, quinolinyl, isoquinolinyl, and the like.
- substituted heteroaryl refers to a heteroaryl group as defined herein, substituted by independent replacement of one, or more of the hydrogen atoms thereon with substituents independently selected from substituents such as, but not limited to, alkyl, haloalkyl, alkoxy, thioalkoxy, amino, alkylamino, dialkylamino, acylamino, hydroxyl, cyano, halo, mercapto, nitro, carboxaldehyde, carboxyl, alkoxycarbonyl, carboxamide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, benzyl, benzyloxy, aryloxy, heteroaryloxy, C 1 -C 6 -alkoxy, methoxymethoxy, methoxyethoxy, amino, benzylamino, arylamino, heteroarylamino, C l -C 3 -alkylamino,
- substituents include, but are not limited to, F, Cl, Br, I, OH, NO 2, CN, C(O)—C 1 -C 6 -alkyl, C(O)-aryl, C(O)-heteroaryl, CO 2 -alkyl, CO 2 -aryl, CO 2 -heteroaryl, CONH 2 , CONH—C 1 -C 6 -alkyl, CONH-aryl, CONH-heteroaryl, OC(O)—C 1 -C 6 -alkyl, OC(O)-aryl, OC(O)-heteroaryl, OCO 2 -alkyl, OCO 2 -aryl, OCO 2 -heteroaryl, OCONH 2 , OCONH—C 1 -C 6 -alkyl, OCONH-aryl, OCONH-heteroaryl, NHC(O)—C 1 -C 6 -alkyl, NHC(O)—C
- hydrophilic group refers to a group which will improve the solubility of the molecule in water.
- suitable hydrophilic groups which may be incorporated in the novel fluorescent compounds of the invention include: carboxylic acids (—COOH); polyethers such as those represented by —(OCH 2 CH 2 ) a -Oet where a is an integer of from 1 to 20 such as polyethylene oxide; polyalcohols which are represented by —CH 2 —(CHOH) b —CH 2 OH, where b is an integer of from 1 to 20; primary, secondary or tertiary amines, sulfonic acids (—SO 3 H), phosphonic acids or esters which are represented by —(CH 2 ) c —PO(OR 17 )(OR 18 ) where c is an integer of from 1 to 8 and R 17 and R 18 each independently is hydrogen, alkyl, preferably having from 1 to 6 carbon atoms or aryl such as phenyl.
- a general definition is a delocalized pi cyclic system which exhibits diamagnetic ring current and in which all of the ring atoms are involved in a single conjugated system.
- heteromatic refers to aromatic compounds with one or more elements other than carbon in the ring.
- aroyl refers to a group derived from an aromatic carboxylic acid minus the carboxyl OH group.
- heteroaroyl refers to a group derived from a heteroaromatic carboxylic acid minus the carboxyl OH group.
- the dyes and labeled conjugates of the invention may be prepared by reactions which are known to those skilled in the art and these will be apparent from the specific synthetic preparative scheme provided below.
- Compounds of the invention as shown in Formula I can be synthesized as shown in the following scheme:
- 2-(2′-Hydroxy-4′-cyanophenyl) benzazole (1) can be made by reacting 2-hydroxy-4-cyano benzoic acid with 2-amino phenol/thiol/selenol in the presence of a cyclodehydrating agent like PCl 3 or P 2 O 5 [Terashima, M et al, Synth. 484 (1982), D. W. Hein et al, J. Am. Chem. Soc. 79, 427 (1957), Freyermuth, H. B et al, U.S. Pat. No. 3,669,979 (1972)].
- 1 can be converted to 3 as described by Kim, T et al [Chemical Commun. 5895 (2009)].
- 3 can be converted to the benzamidic acid ethyl ester 4 by reaction with HCl in absolute ethanol. Reaction of 4 with NaOH will give the target product 5.
- Compounds of the invention as shown in Formula II can be made by reacting a suitably substituted aniline with 3-hydroxy-quinoline-4-carboxylic acid in polyphosphoric acid at 120° C. for about 18 hours as shown below.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
There are described novel fluorescent dyes, conjugates which include a radical of a dye and a biological or a synthetic moiety and diagnostic and in vivo assays utilizing such conjugates and other products including the dyes and conjugates.
Description
- This application is a nonprovisional application of a provisional application, Ser. No. 61/964,131, filed on Dec. 23, 2013, whose disclosure is incorporated by reference in its entirety.
- Aspects of the invention are directed to novel dye compounds and, more particularly, to novel dye compounds which are useful as fluorescent reporters for use in diagnostic assays, and to labeled conjugates and diagnostic and in vivo assays utilizing the compounds and conjugates.
- Historically, biomolecules labeled with radioactive isotopes or colorimetric dyes have been employed in bioanalytical procedures. The inherent disadvantages of radioactive labels (safety concerns, disposal costs, record keeping and often poor label stability) and low sensitivity of colorimetric dyes have led to increasing use of luminescent molecules as reporters. Besides having the potential of higher sensitivity than radioactive or colorimetric reporters, luminescent reporters also allow simultaneous detection of multiple analytes, improved stability, reduced costs, improved spatial resolution and greater scope for signal modulation, a feature which permits homogeneous assays to be designed.
- Two types of luminescence methods have been employed in bioassays. They are chemiluminescence and fluorescence. Chemiluminescence refers to the transient emission of light during an enzymatic reaction. Fluorescence is the emission of longer wavelength (visible region) of light by a molecule when excited by shorter wavelength (usually in the UV region) of light. If the luminescence is generated by an enzyme, an extra level of amplification is added to the system. Although, chemiluminescence is often regarded as the most sensitive signal system, fluorescence has certain advantages over chemiluminescence. A chemiluminescent molecule can decay only once, giving a single photon, while a fluorophore is continuously excited, having the capacity to emit tens of thousands photons before losing fluorescence due to chemical degradation or photobleaching. Other disadvantages of chemiluminescence include: laborious requirements for use, limitations on sensitivity arising from the transience of chemiluminescence itself, and, the broad spectral emission which precludes the simultaneous detection of multiple analytes in a single sample.
- At its limit, fluorescence can detect single molecules either by fluorescence correlation spectroscopy or other methods. However, in practice, the extreme sensitivity potential is limited by interfering signals (noise). These signals may originate from biological components, plastics, reagent impurities, light scattering from particles, background light (“stray” light) which exists in all fluorescence detectors because of the light source used to induce excitation, contamination from a variety of sources, poor aqueous solubility of fluorogenic molecules, significant photoquenching and poor photostability in aqueous solutions and low turnover rates of available fluorogenic substrates by their specific enzymes.
- Frequently, in biochemical and immunochemical assays, it is the noise, rather than the instrumentation, that limits sensitivity. As a result, progress in fluorescence has largely been about obtaining selectivity, i.e. improving the signal-to noise ratio. Several techniques have been developed to avoid the noise problem. Time resolved fluorescence, fluorescence correlation spectroscopy and confocal microscopy largely eliminate noise problems since only fluorophores in solution are detected. There is also a trend towards the use of fluorophores that are excited and emit at longer wave lengths where noise sources are less of an issue. Signals from fluorophores with large Stokes' shifts are more easily distinguished from noise.
- Unlike a chemiluminescent molecule, a fluorescent molecule can be derivatized so that it can be used either (i) to covalently attach as a fluorescent tag or (ii) as a “fluorogenic” enzyme substrate which can be converted by the action of an enzyme specific for that substrate, into a fluorescent product which exhibits greatly enhanced fluorescence as compared to the starting substrate. The rate or extent to which a substrate for that enzyme has been converted into a detectable chemiluminescent or fluorogenic final product is used to detect or measure the activity of the enzyme.
- In biological assays, the activity of an enzyme is used to indirectly detect or measure the quantity of a complementary biological “target”. Hydrolytic enzymes such as alkaline phosphatase, β-galactosidase, β-glucuronidase and β-glucosidase have been widely used in conjunction with fluorogenic substrates. These enzymes act on substrate molecules which have been derivatized at hydroxyl moieties to create phosphoric acid, galactoside, glucuronide and glucoside substrates, respectively, and the parent fluorescent molecule. Derivatives of fluorescein, ATTOPHOS® dyes, and BODIPY® dyes are some of the commercially available dyes for this purpose.
- U.S. Pat. No. 5,443,986 (Haughland et al.)discloses detecting the activity of enzymes and enzyme conjugates using substrates made from a class of fluorophores generally including quinazolines, benzimidazoles, benzothiazoles,benzoxazoles, quinolines, indolines and phenanthradines.
- Kauffman et. al. (Chemical Abstracts, 130: 174202, 1999) discloses p-transfer fluors as shifters for green-emitting scintillating fibers of multi-fiber lengths.
- International Patent Application Publication No. WO 00/03034 (Conrad et al.) describes halo-pyrene-disulfonic acids and their derivatives as potential fluorogenic dyes for hydrolytic enzymes. These compounds are described as being highly water soluble, highly stable to non-enzymatic hydrolysis and rapidly converted to the parent fluorescent products (with long wave lengths of excitation and large Stokes' shifts) by the action of appropriate enzymes. This patent also reviews the state of the art as it applies to pyerene derivatves.
- U.S. Pat. No. 5,424,440 (Klem et al.) describes several hydroxy benzothiazoles derivatized at the hydroxy group with protective groups that can be cleaved with esterases. The following advantages were described for these compounds: stability in aqueous environment; easily detectable above background interference; highly fluorescent in a variety of solvents; sufficient Stokes' shift; sensitive enough to detect alkaline phosphatase at 10 attomolar concentration; long life time; and some members could be excited with visible light. The fluorogenic phosphates were stable in water and could be hydrolyzed to fluorescent compounds. This patent includes a review of the state of art at the time it was filed.
- U.S. Pat. No. 5,587,112 (Kauffman et al.) describes alkaline phosphate substrates derived from 2-benzazolyl dibenzofurans, 2-benzazolyl dibenzothiophenes and 2-benzazolyl carbazoles. These belong to a class of fluorescent compounds called “excited state intramolecular proton transfer” (ESIPT) fluors. The phenomenon of ESIPT fluorescence results in large Stokes' shifts. Solutions of the ESIPT 2-benzazole fluors claimed in the '112 patent absorb strongly in the UV to blue spectral region, i.e., about 420 nm or shorter, with absorption maxima in the UV indicating an extinction coefficient of about 37,000 or greater. These 2-benzazole fluors possess unusually strong, UV stimulated, proton transfer fluorescence in the visible spectral region, having a fluorescence emission peak at about 520 nm or longer at room temperature or above room temperature. These compounds also exhibit fluorescence quantum yields of 0.5 or greater at 300° K.
- Molecular Probes, Inc. catalog, 6th Edition, 1996, page 117 lists ESIPT fluor, ELF-97(a quinazolinone) and describes its applications in in situ hybridization, cytological labeling, immunohistochemistry and endogenous phosphate detection. This compound and other quinazolinones, benzothiazoles, benzoxazoles, benzimidazoles, quinolines, indolines and phenanthridines are claimed in U.S. Pat. No. 5,443,986. The preferred fluorogenic substrates described in this patent are said to have the following properties:
-
- a. generally soluble and non-fluorescent in water but capable of releasing a highly fluorescent solid product in an aqueous solution containing the fluorogenic substrate and the specific hydrolase;
- b. an excitation maximum of greater than about 340 nm and a Stokes' shift of about 100 nm for the solid product; and
- c. the fluorescent solid is highly resistant to photobleaching.
- Tae-Il Kim et al (Chem.Commun., 5895, 2009) described the synthesis of the phosphate derivative of 2-(2′-hydroxyphenyl) benzothiazole(HBT) as substrate for protein tyrosine phosphatase. HBT is a known ESIPT fluor with a large Stokes shift. However HBT has low quantum efficiency. The compounds claimed in this patent have high quantum efficiencies besides possessing large Stokes shifts, radiation, thermal and chemical stability and good solubility in a wide range of solvents.
- As the state of the diagnostic assay art advances there is a continuing need for new fluorogenic dyes which can be activated enzymatically or photolytically and conjugates labeled with novel fluorescent molecules which are useful in diagnostic assays.
- In one aspect of the invention there are provided novel fluorescent dyes which are represented by Formula I
- wherein
- D is selected from —C—R5, —C-(A) q-R6, E+(G−), and
- X is selected from oxygen, sulfur, selenium, N—B, and —C (═O) O—;
- B is selected from hydrogen, alkyl having from 1 to 10 carbon atoms, aryl, heteroaryl, acyl, aroyl having from 1 to 10 carbon atoms and heteroaroyl having from 1 to 10 carbon atoms);
- Z is carbon or nitrogen;
- Za is selected from carbon, nitrogen and —C-(A)q-R6;
- Zb is selected from carbon, N-alkyl and N-aryl;
- A is a divalent linking group having alternating single and multiple bonds such as, for example, —CH═CH—, —C≡C—, CH═CH—CH═CH—, —C≡C—C≡C—, —CH═CH—C≡C—, —C≡C—CH═CH— and the like; or a combination of multiple bonds conjugated with an unsaturated ring system which may be aromatic or heteroaromatic such as, for example,
- E+ is oxygen or N+—R7, where R7 is hydrogen, cyano, alkyl, linear or branched, preferably having from 1 to 10 carbon atoms, arylalkyl, preferably having from 1 to 10 carbon atoms or heteroarylalkyl, preferably having from 1 to 10 carbon atoms;
- (G−) is any suitable counterion such as, for example, chloride, cyano, sulfate, sulfonate, trifluoroacetate, phosphate, hexafluorophosphate, tetrafluoroborate, etc.;
- Y is a proton transfer group; such as, for example, —OH, NH2, —NHSO2Ar, —NHSO2OH, —NHC(═O)Ar, —NHC(═O)OH, —O(PG),
- —N(PG)SO2Ar, —N(PG)SO2OH, —N(PG)C(═O)Ar and —N(PG)C(═O)OH;
- Ar is an aromatic or a heteroaromatic moiety;
- PG is a protective group;
- R1, R2 and R3 each independently is selected from hydrogen, an electron withdrawing group and an electron releasing group; or
- R1 and R2 taken together with the carbon atoms to which they are attached represent the carbon atoms necessary to form a substituted or unsubstituted unsaturated carbocycic or heteroaromatic ring;
- R4 is selected from hydrogen, an electron withdrawing group and an electron releasing group;
- R5 is selected from hydrogen and a 5 or 6 member aromatic or heteroaromatic ring such as, for example, 4-cyanophenyl or 4-quinolyl, or R2 and R5 taken together with the carbon atoms to which they are attached represent the carbon atoms necessary to form an unsaturated carbocyclic or heteroaromatic ring system such as, for example, a 7,7-disubstituted-7H-indeno[2,1-quinoline ring or a 9.9-disubstituted-9H-fluorene ring;
- R6 is
- where
- R11 is hydrogen, alkyl, aryl, heteroaryl, H2W or R13R14;
- R12 is hydrogen, alkyl, aryl or heteroaryl;
- R13 is hydrogen;
- R11 and R12 taken together with the nitrogen and oxygen atoms to which they are attached represent the carbon atoms necessary to form a substituted or unsubstituted, saturated or unsaturated ring as shown in the examples below.
- R14 is alkyl, aryl or heteroaryl;
- W is any suitable anion such as a halide or a sulfate n is an integer of from 0 to 4; and q is 0 or 1, provided that at least Za or D is —C-(A) q-R6 .
- Typical suitable electron releasing groups which are suitable for R1 , R2 , R3 and R4 include linear or branched chain alkyl (C1-C10), methoxy, hydroxyl, amino, (C1-C10 alkyl) amino, (C1-C10 dialkyl)amino, (C1-C10 acyl) amido, (C1-C10 aroyl) amido, (C1-C10 acyl) oxy, (C1-C10 aroyl) oxy, aryl and halogens.
- Typical electron withdrawing groups which are suitable for R1 , R2 , R3 and R4 include nitrile, nitro, R8—C(═O), (R8═Cl-C10). Ar1—C(═O) (Ar1=aryl, heteroaryl), —C(═O)—O—R8, —C(═O)—O—Ar1, —C(═O)—OH, —C(═O)—NH2 , —C(═O)—NHR9, —C(═O)—NR9R10, where R9 and R10 are each independently alkyl or aryl;
- Typical suitable proton transfer groups include —OH, —NHSO2Ar, —NHSO2OH, —NHC(═O)Ar, —NHC(═O)OH, —O(PG). —N(PG) SO2Ar, —N(PG)SO2OH, —N(PG)C(═O)Ar, —N(PG)C(═O)OH and the like. Ar may be substituted with one or more electron releasing or electron withdrawing groups. Typical examples of substituents are methyl and t-butyl groups. Preferred proton transfer groups are those having a pKa between about 5 and about 15 or such a group in which the transferable proton has been replaced with a protective group PG. The proton transfer groups may be photo-cleavable groups. The compounds with a transferable proton are fluorescent while the compounds where this proton has been replaced with a protective group are weakly fluorescent or non-fluorescent. The protective group, PG. can be cleaved and a proton substituted in its place by hydrolytic enzymes or by photolysis.
- Typical suitable protective(blocking) groups for use as PG include phosphate (PO3H2), mono and di salt anion of phosphate, mono and di salt anion of sulfate, galactose, sialic acid, glucose, glucuronic acid, amino acids, peptides or the same protected with a blocking group, lipids, nucleic acids, 4-guanidino-benzoate, alkylether derivatives and the like
- These protective groups can be cleaved by enzymes such as alkaline phosphatase, sulfatase, beta-galactosidase, neuraminidase, beta-glucosidase, beta-glucuronidase, various proteases, lipases and nucleases, guanidinobenzoatase, and microsomal dealkylases, respectively. In fluorescence assay literature such enzymes are called “signal enzymes”. Amidases and N-dealkylases are examples of signal enzymes that can be used when Y═N(PG)SO2Ar or —N(PG)C(═O)Ar. Typical examples of photo-cleavable protective groups are, 2-nitrobenzyl, alpha-substituted 2-nitrobenzyl (where the alpha substituent is alkyl, aryl, alkoxy, heteroaromatic or alkenyl),2-nitrobenzyloxycarbonyl, alpha substituted 2-nitrobenzyloxycarbonyl, 3,5-dimethoxybenzyloxycarbonyl, α,α-dimethyl-3,5-dimethoxybenzyloxycarbonyl, 3-nitrophenyloxy, 3,5-dinitrophenyloxy and 6-nitroveratryloxycarbonyl. Exposure of the precursor dye to light of appropriate wavelength liberates a pulse of highly fluorescent dye.
- When Y is a phosphate group (i.e. Y═—OPO3H2), for example, an enzyme such as alkaline phosphatase can be used to generate the fluorescent 2-hydroxy-4-benzimidic acid ester of the benzazole of Formula I, which has large Stokes shift, high quantum efficiency and radiation and chemical stability. The Stokes shift and fluorescence quantum efficiency of the dyes can be modified by appropriate substitution of the benzene rings.
- When Y is a photo-cleavable group the compounds are known as “caged” dyes. The blocked or protected precursors are generally non-fluorescent or weakly fluorescent or fluoresce at substantially shorter wavelengths than those of the corresponding unprotected parent dyes. Exposure of the precursor dye to light of appropriate wavelength liberates a pulse of highly fluorescent dye. The blocked precursor can be added to a sample or sample stream and allowed to reach the target area, but only upon photolysis is the desired fluorescent parent molecule produced in the illuminated area. Following photolysis, the subsequent migration, diffusion, photobleaching, enzymatic conversion to non-fluorescent products or localization of the dye can be observed as a function of the time and location since photolysis. A typical blocking group used for this purpose is o-nitroarylmethine. Upon photolysis, the o-nitroarylmethine group is intramolecularly converted to a derivative of o-nitrosophenone. Hydroxy, amino derivatives of anthracene, naphthalenes, coumarins, fluorescein, resorufin and rhodamine have been protected using the o-nitroarylmethine group.
- Some other examples of photolabile groups are, 2-nitrobenzyl, alpha-substituted 2-nitrobenzyl (where the alpha substituent is alkyl, aryl, alkoxy, heteroaromatic or alkenyl), 2-nitrobenzyloxycarbonyl, alpha substituted 2-nitrobenzyloxycarbonyl, 3,5-dimethoxybenzyloxycarbonyl, α,α-dimethyl-3,5-dimethoxybenzyloxycarbonyl, 3-nitrophenyloxy, 3,5-dinitrophenyloxy and 6-nitroveratryloxycarbonyl.
- These dyes can be made water soluble by attaching hydrophilic groups such as sulfonic acid or its salts. These water soluble “caged” dyes can then be used in aqueous systems (e.g. physiological fluids) to conduct studies such as flow analysis, velocimetry, analysis of ligand-receptor interactions etc.
- Photochemically fluorogenic molecules can also be used in imaging systems. For example, a benzazole of the type shown in Formula 1 protected with a photolabile group can be used in the preparation of printing plates.
- A preferred group of compounds according to the invention is represented by Formula II
- (II)
- wherein
- R15 is selected from hydrogen, an electron withdrawing group and an electron releasing group;
- R16 is selected from hydrogen, an electron withdrawing group and an electron releasing group;
- m is 0 or 1;
- o is an integer of from 0 to 4; and
- E, G, X, Y, Z, Za, Zb, R4, R6, q and n are as previously defined.
- Another preferred group of compounds according to the invention is represented by Formula III.
- where X and Y are as previously defined.
- Another preferred group of compounds according to the invention is represented by Formula IV
- where Y is as previously defined
- Representative compounds of the invention are:
- Various of the substituents in the formulas have been defined as being an electron withdrawing or an electron releasing group. It should be noted that the electron withdrawing or electron releasing groups can be modified to include hydrophilic groups to improve the water solubility of the compounds. Typical suitable hydrophilic groups which may be incorporated in the novel fluorescent compounds of the invention are recited together with the definition of “hydrophilic group” below herein.
- The fluorophores of the invention described herein belong to the class of ESIPT fluors. These compounds have the advantages of high fluorescence quantum efficiency, large Stokes' shift and high chemical and radiation stability. These compounds have an added advantage since they exhibit intense fluorescence in aromatic hydrocarbons such as benzene and toluene. The fluor released by an esterase from its precursor can be extracted with toluene and its intensity measured in toluene. Since other biomolecules have negligible solubility in toluene there will be no interference due to background noise. By varying the substituents on these compounds their spectral properties can be modified. The ESIPT fluorescent dyes described herein are suitable for the preparation of plastic scintillators which are part of the detector system of particle accelerators and also in liquid scintillation products. Plastic scintillators typically include a fluorescent molecule dissolved in a matrix material which is transparent in at least a portion of the visible electromagnetic radiation spectrum such as polystyrene and are used for the detection and measurement of ionizing radiation. Ionizing radiation, upon striking the matrix material, causes it to emit UV radiation which is absorbed by the fluorescent molecule which then emits visible radiation. Liquid scintillation cocktails contain a fluorescent molecule dissolved in a solvent such as toluene and other additives. Liquid scintillation products are used for measuring radiation emitted by biomolecules labeled with a radioisotope such as 32P (see, for example, U.S. Pat. Nos. 5,298,189; 5,552,551 and 5,587,112).
- Fluorescent dyes are widely used as tracers for localization of biological structures by fluorescence microscopy, for quantification of analytes by fluorescence immunoassay, for flow cytometric analysis of cells, for measurement of physiological state of cells, for quantification assays such as DNA sequencing, and other applications (Haugland et al., U.S. Pat. No. 5,442,045). Fluorescent dyes are also used for the determination of ions like Calcium and gases like nitric oxide The isothiocyanate derivatives of these dyes can also be used for protein/peptide sequencing by the Edman degradation procedure (see Jin, S. W. et al., FEBS Lett. 150, 198, 1986; Hirano, H. et al., Biol. Chem. Hoppe-Seyler, 1259, 367, 1980).
- In another aspect of the invention there are provided labeled conjugates comprising a radical of a dye molecule of Formulas I-III and a radical of a biological/synthetic (organic, inorganic) moiety. These fluorescent conjugates (probes, labels) are made by attaching chemically reactive fluorescent dyes to reactive sites on a wide variety of materials, both organic and inorganic. Although the biological/synthetic moiety may be attached at various positions on the dye moiety the preferred points of attachment are at the R1, R2 and R3 positions (Formula I) and the various substituents in Formulas II-IV.
- The attachment of the biological/synthetic moiety to the linkage through which it is attached to the dye, or to the dye, may be through any appropriate position on the biological/synthetic moiety which will not negatively affect the intended function of the biological/synthetic moiety.
- Generally, the novel conjugates of the invention include at least one biological/synthetic moiety which can be attached directly to the dye or which can be attached to the dye through a divalent achromophoric linking group. By the term “achromophoric linking group” is meant one which does not cause any appreciable shift in the spectral absorption characteristics of the dye moiety. The linkage should be non-conjugated. The linking group may also have a chelating group.
- The selection of the covalent linkage to attach the benzazoles to the conjugated substance typically depends on the functional group on the substance to be conjugated. The types of functional groups typically present on the organic or inorganic substances include, but are not limited to, amines, thiols, alcohols, phenols, aldehydes, ketones, phosphates, imidazoles, hydrazines, hydroxylamines, disubstituted amines, halides, epoxides, sulfonate esters, purines, pyrimidines, carboxylic acids, or a combination of these groups. A single type of reactive site may be available on the substance (typical for polysaccharides), or a variety of sites may occur (e.g. amines, thiols, alcohols, phenols), as is typical for proteins. Although some selectivity can be obtained by careful control of the reaction conditions, selectivity of labeling is best obtained by selection of an appropriate reactive dye.
- Typical functional groups which are useful as coupling groups which can be attached to the dye molecule, and the substituents of the biological/synthetic moiety with which such coupling groups can be reacted to provide the achromophoric linking group within the labeled conjugate are listed in Table I.
-
TABLE I Coupling Group Substituent N-hydroxysuccinimide esters amino esters (α-amino, lysine) Imidoester amino groups Aldehydes amino groups Mixed anhydrides nucleophilic groups Isothiocyanates nucleophilic groups 2,4-Dichloro-5-triazine nucleophilic groups Diazonium salts tryptamine, histamine Bromoacetyl histamine, —SH Maleimido —SH Activated disulfide bonds —SH (e.g., 2-pyridyldisulfides) Azides, diazirinyl, azidoaryl amines, anilines - A more detailed list of coupling groups appears in
- U.S. Pat. No. 5,696,157.
- Many other linking groups may be incorporated into the labeled conjugates of the invention. For example, the hydrophilic groups mentioned above are substantially achromophoric and certain of these can be derivatized and utilized as suitable linking groups. For example, an —NH2 group can be converted to an amide as a result of attaching the biologically active moiety (“BIO”) to it, i.e., —NHCO-BIO. Further, in another embodiment a hydrophilic group may be attached to the linking group. For example, in the case of a primary amine one of the hydrogen atoms is replaced by a biologically active moiety attached to it as described above and the other hydrogen atom can also be replaced by a hydrophilic group such as, for example, —(CH2)2PO3H2. Thus, it will be appreciated that the linking group, while serving as the means for attaching the dye moiety to the biologically active moiety, can also have a hydrophilic group attached to it. In addition, the linking group may also function as a hydrophilic group such as, for example, in the case of —NH,-BIO and —PO2(OH)-BIO. Solubilizing groups may also be attached to suitable positions on the dyes. The presence of such solubilizing groups can help to avoid undesirable nonspecific binding of the conjugates to components present in biological fluids such as, for example, plasma proteins.
- The fluorescent dyes and labeled fluorescent conjugates of the invention may be used in various applications including diagnostic assays which are based on an energy transfer to fluorescent label and assays which are based on enzymatic attack on the conjugate to release the fluorescent moiety, in vivo imaging applications, analytical methods, etc. In medical imaging techniques, e.g., X-ray imaging, positron emission tomography (PET), ultrasound imaging and magnetic resonance imaging (MRI), a narrow band frequency radiation illuminates an object of interest to produce reflected or emitted radiation which is then gathered from the object by a detector. The reflected or emitted radiation is then processed by an imaging algorithm to obtain useful information about the object. The use of ionizing radiation in imaging, for example, with X-rays involves significant health risks to a patient when the patient is exposed to the radiation for prolonged periods of time or in multiple imaging schemes. Furthermore, certain of these imaging techniques undesirably involve the use of invasive procedures which are both costly and painful. Yet other techniques such as MRI do not yield consistently useful results. Imaging techniques involving measurement of light emitted by fluorescent molecules localized in an organ afford non-invasive, safe and relatively fast methods for selectively highlighting in vivo biological targets, biomarkers and pathways that underlie disease progression and therapeutic response. In practice the fluorescent molecules alone or the fluorescent conjugates are injected into a patient. The moiety attached to the fluorescent dye radical in the conjugate can assist in targeting the fluorescent molecule to a specific particular site. See, for example, U.S. Pat. Nos. 6,304,771 and 7,303,741.
- With these synthetic probes, ligands are frequently used to confer a specificity for a biochemical reaction that is to be observed and the fluorescent dye provides the means of detection or quantitation of the reaction. The ligand is usually a member of activate the a pair of molecules that can bond together with a high degree of specificity. Examples of specific binding pairs are shown in Table II. Binding pair members present in animal cells, plant cells, bacteria, yeast or viruses can be detected with fluorescent probes. The complementary member may also be immobilized on a solid or semi-solid surface such as a polymer, polymeric membrane or polymeric particle. The fluorescent dye may also have a protective group PG which can be cleaved enzymatically or by photolysis after binding to the complementary member (see, for example, U.S. Pat. No. 5,696,157 to Haughland).
-
TABLE II Antigen Antibody Biotin Avidin (or streptavidin or anti- biotin IgG Protein A or Protein G Drug Drug receptor Toxin Toxin receptor Carbohydrate Lectin or carbohydrate receptor Peptide Peptide receptor Protein Protein receptor Enzyme substrate Enzyme DNA (RNA) aDNA (aRNA)* Hormone Hormone receptor Ion Chelator - aDNA and aRNA are the antisense strands used for hybridization.
- In general, it is desirable that fluorescent labels for use in such assays have a relatively long emission wavelength, e.g., above 500 nm. In addition, it is desirable that the labels have a large Stokes shift, be stable under the assay conditions, be relatively free of non-specific interference both from materials in solution and the moiety to which the label is conjugated and exhibit high quantum yields. Also, it is desirable to have dyes whose fluorescence is not quenched in aqueous solutions.
- Useful dye-conjugates of the present invention include conjugates of biomolecules (antigens, haptens, an Fab fragment, amino acids, peptides, proteins, nucleic acids, nucleic acid polymers, carbohydrates, lipids), drugs, vitamins, metabolites, toxins, environmental pollutants, pesticides, ion-complexing moieties, cells or cellular components.
- Alternatively, the conjugates of the present invention are conjugates of cells, cellular systems, cellular fragments or sub-cellular particles. Typically, in this embodiment of the invention the conjugated materials include virus particles, bacterial particles, virus components, biological cells (such as animal cells, plant cells, bacteria or yeast) or cellular components.
- In one embodiment of the invention, the conjugated substance is an amino acid or a polymer of amino acids such as a peptide or protein. Amino acids mean natural amino acids or their optical isomers, as well as synthetic variations utilized in the art. Common synthetic variations include amino acids that are protected on their amino, carboxylic acid, hydroxyl, thiol, imidazole or other functional group. Other modified amino acids are substituted by phosphate, or through glycosylation or acylation with a C1 to C22 carboxylic acid. Peptides generally have molecular weights of less than about 5,000 to 10,000 daltons, and proteins have molecular weights greater than about 5,000 to 10,000 daltons and typically possess secondary, tertiary and/or quaternary structure. Preferred conjugates of peptides contain at least five amino acids, more preferably 5 to 36 amino acids. Preferred peptides to be conjugated to the dyes of the invention include, but are not limited to, neuropeptides, chemotactic peptides, cytokines (such as lymphokines), gastrointestinal peptides, toxins, protease substrates, synthetic peptides, experimental peptides, endothelin and protein kinase substrates. Protein conjugates of the invention include labeled enzymes, antibodies, catalytic antibodies, kinases, lectins, glycoproteins, histories, albumins, lipoproteins, avidin, streptavidin, protein A, protein G, phycobiliproteins, hormones, toxins and growth factors. Typically, the conjugated protein is an antibody, an antibody fragment, avidin, streptavidin, α-bungarotoxin, a lectin, a growth factor, or a phallotoxin.
- In another embodiment of the invention, the conjugated substance is a single nucleic acid base, single nucleoside, single nucleotide or a nucleic acid polymer. A nucleotide comprises an ester of a nucleoside and one or more phosphoric acid or polyphosphoric acid groups, optionally containing an additional linker or spacer for attachment of a fluorophore or other ligand, such as an alkynyl linkage (U.S. Pat. No. 5,047,519 to Hobbs, Jr. et al., (1991), incorporated by reference), an aminoallyl linkage (U.S. Pat. No. 4,711,955 to Ward et al. (1987), incorporated by reference) or other linkages. Nucleotides, as used herein, include natural and synthetic derivatives, including deoxynucleotides, dideoxynucleotides, cyclonucleotides and abasic nucleotide analogs, wherein the base is replaced by a fluorophore or hapten. Preferably, the conjugated nucleotide is a mono-, di- or triphosphate ester of an adenosine, a guanosine, a uridine, a cytidine or a thymidine. More preferably, the conjugated nucleotide is a nucleoside triphosphate or a deoxynucleoside triphosphate or a dideoxynucleoside triphosphate.
- Preferred conjugates of nucleic acid polymers are labeled oligonucleotides composed of fewer than 50 nucleotides, more typically composed of fewer than 25 nucleotides. Oligonucleotides are optionally deoxyribonucleic acid polymers (DNA) or ribonucleic acid polymers (RNA), or a hybrid thereof. Nucleic acid polymers are optionally single-stranded or multi-stranded; and may be a natural polymer (biological in origin) or a synthetic polymer (modified or prepared artificially). The nucleic acid polymer optionally incorporates an unusual linker such as morpholine derivatized phosphates (Antivirals, Inc., Corvallis Oregon), or peptide nucleic acids such as N-(2-aminoethyl)glycine units (Wittung, et al., NATURE 368, 561 (1994)). In one embodiment of the invention, the dye is attached to the nucleotide, oligonucleotide or nucleic acid polymer via one or more purine or pyrimidine bases through an amide, ester, ether or thioether bond. In another embodiment of the invention, the dye is attached to the phosphate or carbohydrate by a bond that is an ester, thioester, amide, ether or thioether.
- In another embodiment of the invention, the conjugated substance is a carbohydrate, i.e. an organic compound composed of carbon, hydrogen and oxygen and occasionally nitrogen or sulfur, that include sugars, starches and celluloses. The conjugated substance is typically a polysaccharide, such as dextran, FICOL, heparin, glycogen, amylopectin, mannan, inulin, starch, agarose and cellulose, all of which are readily available. Preferred polysaccharide conjugates are dextran or FICOL conjugates, more preferably a dextran conjugate.
- In another embodiment of the invention, the conjugated substance is a lipid. Lipids are long-chain saturated or unsaturated aliphatic hydrocarbons (typically having 6-25 carbon atoms) and their derivatives, such as fatty acids, alcohols, amines, amino alcohols, and aldehydes. The class of lipids includes glycolipids, phospholipids and sphingolipids. Alternatively, the conjugated substance is a lipid vesicle, such as a liposome, or is a lipoprotein. Alternatively, the dye contains a lipophilic substituent, e. g. a linear saturated or unsaturated fatty alkyl group, typically with 12-18 carbon atoms.
- In another embodiment of the invention, the conjugated substance is a drug or toxin. Where the conjugated substance is a drug, preferred drugs of interest are the alkaloids (including morphine alkaloids), steroids, lactams having from 5 to 6 annular members, aminoalkylbenzenes, benzheterocyclics, purines, marijuana-derived drugs, vitamins, prostaglandins, antibiotics and aminoglycosides, as well as their individual derivatives and metabolites. Metabolites related to diseased states include spermine, galactose, phenylpyruvic acid and porphyrin Type 1. Among pesticides of interest are polyhalogenated biphenyls, phosphate esters, thiophosphates, carbamates, polyhalogenated sulfenamides, their metabolites and derivatives.
- The conjugated substance is optionally an ion-complexing moiety. Preferred ion-complexing moieties are crown ether, including diaryldiaza crown ethers, as described in U.S. Pat. No. 5,405,975 to Kuhn et al. (1995); derivatives of 1,2-bis-(2-aminophenoxyethane)-N,N,N′,N′-tetraacetic acid (BAPTA), as described in U.S. Pat. No. 5,453,517 to Kuhn et al. (1995), U.S. Pat. No. 5,516,911 to London et al., and U.S. Pat. No. 5,049,673 to Tsien et al. (1991) (all incorporated herein by reference); derivatives of 2-carboxymethoxyaniline-N,N-diacetic acid (APTRA), as described by Ragu et al. AM. J. PHYSIOL. 256, C540 (1989); and pyridine- and phenanthroline-based metal ion chelators, as described in U.S., Pat. No. 5,648,270 to Kuhn et al. Preferably the conjugated ion-complexing moiety is a diaryldiaza crown ether chelator or a BAPTA chelator.
- Conjugates of non-biological polymers are also useful aspects of the invention, including dye-conjugates of synthetic polymers, polymeric particles (including magnetic and non-magnetic microparticles) polymeric membranes, conducting and non-conducting metals and non-metals, and glass and plastic surfaces and particles. Conjugates are optionally prepared by copolymerization of a benzazole dye that contains an appropriate functionality (for example an acrylic acid- or styryl-substituent) while preparing the polymer, or more commonly by chemical modification of a polymer that contains functional groups with suitable chemical reactivity. In another embodiment of the invention, the conjugated substance is a glass or silica, which may be formed into an optical fiber or other structure. Other types of reactions that are useful for preparing dye-conjugates, especially of polymers, include catalyzed polymerizations or copolymerizations of alkenes, reactions of dienes with dienophiles, and transesterifications or transaminations.
- In another aspect of the invention there are provided diagnostic assay methods including in vivo diagnostic imaging methods. The labeled conjugates of the invention may be used in any of many applications such as, for example, in diagnostic assays such as sandwich assays, competitive assays, immunometric assays or in immune response reactions employing labeled reagents.
- The particular assays and methods in which the labeled conjugates of the invention find utility, e.g., immunometric assays, sandwich assays, competitive binding assays, in vivo imaging methods, etc. are well known and therefore extensive discussion of such assay and imaging methods is not required here. In such known diagnostic assays a biological reaction or interaction results in the generation of a detectable signal.
- The dyes and labeled conjugates of the invention may also be used for the fluorescent staining of cells. The cells may then be observed under a microscope with the presence of the fluorescent molecule being indicative of the presence of a specific determinative site. Further, the dyes and conjugates may be used for the deletion, separation or other application in a fluorescent activated cell sorter. The fluorescent dyes can also be used for vacuolar staining of yeast and other fungi (see, for example, U.S. Pat. No. 5,445,946) and Gram reaction in bacterial populations (see, for example, U.S. Pat. No. 5,545,535). The fluorescent dyes that are able to preferentially bind to a specific biological molecule in a sample enable the determination of the presence or quantity of that specific molecule. In addition, the specific cellular structures can be monitored with respect too their spatial and temporal distribution in diverse environments. Furthermore, the dyes can be used for the determination of ionic, electrical or metabolic properties of cellular organelles (see, for example, U.S. Pat. No. 5,459,268), immunofluorescence labeling, fluorescent analog cytochemistry, vital staining of organelles, assessment of cell morphology or intracellular coupling with microinjected tracers, measurement of distances between probes by fluorescence energy transfer and measurement of diffusion coefficients and exchange rates by photobleaching recovery (see, for example, Roger Y. Tsien, Ann. Rev. Neurosci. 12, 227, 1989).
- The fluorescent conjugates of organophosphorus nerve agents can be used for the screening and selection of nerve agents (Luis, Briseno-Roa et al, J. Med. Chem. 49, 246, 2006).
- Definitions
- The term “aryl,” as used herein, refers to a mono-, bicyclic or tricyclic carbocyclic ring system having one, two or three aromatic rings including, but not limited to, phenyl, naphthyl, anthryl, azulyl, tetrahydronaphthyl, indanyl, indenyl and the like.
- The term “substituted aryl,” as used herein, refers to an aryl group, as defined herein, substituted by independent replacement of one or more of the hydrogen atoms thereon with substituents independently selected from substituents such as, but not limited to, alkyl, haloalkyl, alkoxy, thioalkoxy, amino, alkylamino, dialkylamino, acylamino, hydroxyl, cyano, halo, mercapto, nitro, carboxaldehyde, carboxyl, alkoxycarbonyl, carboxamide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, benzyl, benzyloxy, aryloxy, heteroaryloxy, C1-C6-alkoxy, methoxymethoxy, methoxyethoxy, amino, benzylamino, arylamino, heteroarylamino, C1-C3-alkylamino, thio, aryl-thio, heteroarylthio, benzyl-thio, C1-C6-alkyl-thio, or methylthiomethyl. Representative substituents include, but are not limited to, F, Cl, Br, I, OH, NO2, CN, C(O)—C1-C6-alkyl, C(O)-aryl, C(O)-heteroaryl, CO2-alkyl, CO2-aryl, CO2-heteroaryl, CONH2, CONH—C1-C6-alkyl, CONH-aryl, CONH-heteroaryl, OC(O)—C1-C6-alkyl, OC(O)-aryl, OC(O)-heteroaryl, OCO2-alkyl, OCO2-aryl, OCO2-heteroaryl, OCONH2, OCONH—C1-C6-alkyl, OCONH-aryl, OCONH-heteroaryl, NHC(O)—C1-C6-alkyl, NHC(O)-aryl, NHC(O)-heteroaryl, NHCO2-alkyl, NHCO2-aryl, NHCO2-heteroaryl, NHCONH2, NHCONH—C1-C6-alkyl, NHCONH-aryl, NHCONH-heteroaryl, SO2—C1-C6-alkyl, SO2-aryl, SO2-heteroaryl, SO2NH2, SO2NH—C1-C6-alkyl, SO2NH-aryl, SO2NH-heteroaryl, C1-C6-alkyl, C3-C6-cycloalkyl, CF3, CH2CF3, CH2Cl2, CH2OH, CH2CH2OH, CH2NH2 , CH2SO2CH3, tetrafluorophenyl and pentafluorophenyl
- The term “heterocyclic”, as used herein, refers to heterocycloalkyl and heteroaryl. The term “substituted heterocyclic”, as used herein, refers to substituted heterocycloalkyl and substituted heteroaryl.
- The term “heterocycloalkyl,” as used herein, refers to a non-aromatic 3-, 4-, 5-, 6- or 7-membered ring or a bi- or tri-cyclic group comprising fused six-membered rings having between one and three heteroatoms independently selected from oxygen, sulfur and nitrogen, wherein (i) each 5-membered ring has 0 to 1 double bonds and each 6-membered ring has 0 to 2 double bonds, (ii) the nitrogen and sulfur heteroatoms may optionally be oxidized, (iii) the nitrogen heteroatom may optionally be quaternized, and (iv) any of the above heterocyclic rings may be fused to a benzene ring. Representative heterocycles include, but are not limited to, pyrrolidinyl, pyrazolinyl, pyrazolidinyl, imidazolinyl, imidazolidinyl, piperidinyl, piperazinyl, oxazolidinyl, isoxazolidinyl, morpholinyl, thiazolidinyl, isothiazolidinyl, and tetrahydrofuryl.
- The term “substituted heterocycloalkyl”, as used herein, refers to a cycloalkyl group, as defined herein, substituted by independent replacement of one or more of the hydrogen atoms therein with substituents independently selected from substituents such as, but not limited to, alkyl, haloalkyl, alkoxy, thioalkoxy, amino, alkylamino, dialkylamino, acylamino, hydroxyl, cyano, halo, mercapto, nitro, carboxaldehyde, carboxyl, alkoxycarbonyl, carboxamide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, benzyl, benzyloxy, aryloxy, heteroaryloxy, C1-C6alkoxy, methoxymethoxy, methoxyethoxy, amino, benzylamino, arylamino, heteroarylamino, C1-C3-alkylamino, thio, aryl-thio, heteroarylthio, benzyl-thio, C1-C6-alkyl-thio, or methylthiomethyl. Representative substituents include, but are not limited to, F, Cl, Br, I, OH, NO2, CN, C(O)—C1-C6-alkyl, C(O)-aryl, C(O)-heteroaryl, CO2-alkyl, CO2-aryl, CO2-heteroaryl, CONH2, CONH—C1-C6-alkyl, CONH-aryl, CONH-heteroaryl, OC(O)—C1-C6-alkyl, OC(O)-aryl, OC(O)-heteroaryl, OCO2-alkyl, OCO2-aryl, OCO2-heteroaryl, OCONH2,OCONH—C1-C6-alkyl, OCONH-aryl, OCONH-heteroaryl, NHC(O)—C1-C6-alkyl, NHC(O)-aryl, NHC(O)-heteroaryl, NHCO2-alkyl, NHCO2-aryl, NHCO2-heteroaryl, NHCONH2,NHCONH—C1-C6-alkyl, NHCONH-aryl, NHCONH-heteroaryl, SO2—C1-C6-alkyl, SO2-aryl, SO2-heteroaryl, SO2NH2, SO2NH—C1-C6-alkyl, SO2NH-aryl, SO2NH-heteroaryl, C1-C6-alkyl, C3-C6-cycloalkyl, CF3, CH2CF3, CH2Cl2, CH2OH, CH2CH2OH, CH2NH2,CH2SO2CH3. Tetrafluorophenyl and pentafluorophenyl.
- The term “heteroaryl,” as used herein, refers to a cyclic aromatic radical having from five to ten ring atoms of which one ring atom is selected from S, O and N; zero, one or two ring atoms are additional heteroatoms independently selected from S, O and N; and the remaining ring atoms are carbon, the radical being joined to the rest of the molecule via any of the ring atoms, such as, for example, pyridinyl, pyrazinyl, pyrimidinyl, pyrrolyl, pyrazolyl, imidazolyl, thiazolyl, oxazolyl, isooxazolyl, thiadiazolyl, oxadiazolyl, thiophenyl, furanyl, quinolinyl, isoquinolinyl, and the like.
- The term “substituted heteroaryl,” as used herein, refers to a heteroaryl group as defined herein, substituted by independent replacement of one, or more of the hydrogen atoms thereon with substituents independently selected from substituents such as, but not limited to, alkyl, haloalkyl, alkoxy, thioalkoxy, amino, alkylamino, dialkylamino, acylamino, hydroxyl, cyano, halo, mercapto, nitro, carboxaldehyde, carboxyl, alkoxycarbonyl, carboxamide, aryl, substituted aryl, heteroaryl, substituted heteroaryl, benzyl, benzyloxy, aryloxy, heteroaryloxy, C1-C6-alkoxy, methoxymethoxy, methoxyethoxy, amino, benzylamino, arylamino, heteroarylamino, Cl-C3-alkylamino, thio, aryl-thio, heteroarylthio, benzyl-thio, Cl-C6-alkyl-thio, or methylthiomethyl. Representative substituents include, but are not limited to, F, Cl, Br, I, OH, NO2, CN, C(O)—C1-C6-alkyl, C(O)-aryl, C(O)-heteroaryl, CO2-alkyl, CO2-aryl, CO2-heteroaryl, CONH2, CONH—C1-C6-alkyl, CONH-aryl, CONH-heteroaryl, OC(O)—C1-C6-alkyl, OC(O)-aryl, OC(O)-heteroaryl, OCO2-alkyl, OCO2-aryl, OCO2-heteroaryl, OCONH2, OCONH—C1-C6-alkyl, OCONH-aryl, OCONH-heteroaryl, NHC(O)—C1-C6-alkyl, NHC(O)-aryl, NHC(O)-heteroaryl, NHCO2-alkyl, NHCO2-aryl, NHCO2-heteroaryl, NHCONH2,NHCONH—C1-C6-alkyl, NHCONH-aryl, NHCONH-heteroaryl, SO2—C1-C6-alkyl, SO2-aryl, SO2-heteroaryl, SO2NH2, SO2NH—C1-C6-alkyl, SO2NH-aryl, SO2NH-heteroaryl, C1-C6-alkyl, C3-C6-cycloalkyl, CF3, CH2CF3, CH2Cl2, CH2OH, CH2CH2OH, CH2NH2,CH2SO2CH3, tetrafluorophenyl and pentafluorophenyl.
- The term “hydrophilic group” as used herein refers to a group which will improve the solubility of the molecule in water. Typical suitable hydrophilic groups which may be incorporated in the novel fluorescent compounds of the invention include: carboxylic acids (—COOH); polyethers such as those represented by —(OCH2CH2)a-Oet where a is an integer of from 1 to 20 such as polyethylene oxide; polyalcohols which are represented by —CH2—(CHOH)b—CH2OH, where b is an integer of from 1 to 20; primary, secondary or tertiary amines, sulfonic acids (—SO3H), phosphonic acids or esters which are represented by —(CH2)c—PO(OR17)(OR18) where c is an integer of from 1 to 8 and R17 and R18 each independently is hydrogen, alkyl, preferably having from 1 to 6 carbon atoms or aryl such as phenyl.
- The term “aromatic” as used herein refers to mono cyclic planar compounds in which each atom has a p orbital which is part of a pi system with (4n+2) pi electrons, where n=0,1,2,3 etc. Or a general definition is a delocalized pi cyclic system which exhibits diamagnetic ring current and in which all of the ring atoms are involved in a single conjugated system.
- The term “heteroaromatic” as used herein refers to aromatic compounds with one or more elements other than carbon in the ring.
- The term “aroyl” as used herein refers to a group derived from an aromatic carboxylic acid minus the carboxyl OH group.
- The term “heteroaroyl” as used herein refers to a group derived from a heteroaromatic carboxylic acid minus the carboxyl OH group.
- The dyes and labeled conjugates of the invention may be prepared by reactions which are known to those skilled in the art and these will be apparent from the specific synthetic preparative scheme provided below. Compounds of the invention as shown in Formula I can be synthesized as shown in the following scheme:
- 2-(2′-Hydroxy-4′-cyanophenyl) benzazole (1) can be made by reacting 2-hydroxy-4-cyano benzoic acid with 2-amino phenol/thiol/selenol in the presence of a cyclodehydrating agent like PCl3 or P2O5 [Terashima, M et al, Synth. 484 (1982), D. W. Hein et al, J. Am. Chem. Soc. 79, 427 (1957), Freyermuth, H. B et al, U.S. Pat. No. 3,669,979 (1972)]. 1 can be converted to 3 as described by Kim, T et al [Chemical Commun. 5895 (2009)]. 3 can be converted to the benzamidic acid ethyl ester 4 by reaction with HCl in absolute ethanol. Reaction of 4 with NaOH will give the target product 5.
- Compounds of the invention as shown in Formula II can be made by reacting a suitably substituted aniline with 3-hydroxy-quinoline-4-carboxylic acid in polyphosphoric acid at 120° C. for about 18 hours as shown below.
- Although the invention has been described in detail with respect to various preferred embodiments, it will be understood that these are intended to be illustrative only and the invention is not limited thereto, but rather that those skilled in the art will recognize that variations and modifications may be made therein which are within the spirit of the invention and the scope of the appended claims.
Claims (13)
1. A dye compound represented by the formula
X is selected from oxygen, sulfur, selenium, N—B, and —C(═O)O—;
B is selected from hydrogen, alkyl having from 1 to 10 carbon atoms, aryl, heteroaryl, acyl, aroyl having from 1 to 10 carbon atoms and heteroaroyl having from 1 to 10 carbon atoms);
Z is carbon or nitrogen;
Za is selected from carbon, nitrogen and
—C-(A)q-R6 ;
Zb is selected from carbon, N-alkyl ad N-aryl;
A is a divalent linking group having alternating single and multiple bonds;
E+ is oxygen or N+—R7, where R7 is hydrogen, cyano, alkyl, linear or branched, preferably having from 1 to 10 carbon atoms, arylalkyl, preferably having from 1 to 10 carbon atoms or heteroarylalkyl, preferably having from 1 to 10 carbon atoms;
(G−) is a counterion;
Y is a proton transfer group;
Ar is an aromatic or a heteroaromatic moiety;
PG is a protective group;
R1, R2 and R3 each independently is selected from hydrogen, an electron withdrawing group and an electron releasing group; or
R1 and R2 taken together with the carbon atoms to which they are attached represent the carbon atoms necessary to form a substituted or unsubstituted unsaturated carbocycic or heteroaromatic ring;
R4 is selected from hydrogen, an electron withdrawing group and an electron releasing group;
R5 is selected from hydrogen and a 5 or 6 member aromatic or heteroaromatic;
or
R2 and R5 taken together with the carbon atoms to which they are attached represent the carbon atoms necessary to form an unsaturated carbocyclic or heteroaromatic ring;
R6 is
Where R11 is H, alkyl, aryl, heteroaryl, H2W or R13R14;
R12 is hydrogen, alkyl, aryl or heteroaryl;
R13 is hydrogen;
R11 and R12 taken together with the nitrogen and oxygen atoms to which they are attached represent the carbon atoms necessary to form a substituted or unsubstituted, saturated or unsaturated ring as shown in the examples below.
2. A dye compound as defined in claim 1 which is represented by the formula
wherein
R15 is selected from hydrogen, an electron withdrawing group and an electron releasing group;
R16 is selected from hydrogen, an electron withdrawing group and an electron releasing group;
Zb is —C-(A)q—R6;
m is 0 or 1;
is an integer of from 0 to 4; and
E, G, X, Y, Z, R4, R6, q and n are as defined in claim 1 .
4. A fluorescent conjugate comprising a radical of a dye molecule of claim 1 and a radical of a biological or a synthetic organic or inorganic moiety
5. A fluorescent conjugate as defined in claim 4 wherein said radical of a dye molecule is a radical of a dye molecule of claim 2 .
6. A fluorescent conjugate as defined in claim 4 wherein said radical of a dye molecule is a radical of a dye molecule of claim 3 .
7. A fluorescent conjugate as defined in claim 4 wherein said radical of a dye molecule is attached to said radical of a biological or a synthetic organic or inorganic moiety through a non-conjugated divalent achromophoric linking group.
8. A fluorescent conjugate as defined in claim 7 wherein said radical of a dye molecule is attached to a radical of an amino acid or a polymer of amino acids.
9. A fluorescent conjugate as defined in claim 7 wherein said radical of a dye molecule is attached to a biological moiety selected from a nucleic acid base, a nucleoside, a nucleotide and a nucleic acid polymer.
10. A fluorescent conjugate as defined in claim 7 wherein said biological moiety comprises a nucleic acid polymer having fewer than 50 nucleotides.
11. A fluorescent conjugate as defined in claim 7 wherein said radical of a dye molecule is attached to a carbohydrate or lipid moiety.
12. A fluorescent conjugate as defined in claim 7 wherein said radical of a dye molecule is attached to a radical of a drug or a toxin.
13. A diagnostic assay method for determining a component in a biological fluid comprising contacting a biological fluid with a fluorescent conjugate as defined in claim 7 to produce a detectable change which is a function of a component in said biological fluid; and detecting said change.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/187,543 US20160291029A1 (en) | 2013-12-23 | 2016-06-20 | Novel Fluorescent Dyes, Labeled Conjugates and Analytical Methods |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361964131P | 2013-12-23 | 2013-12-23 | |
US14/573,451 US9372194B2 (en) | 2013-12-23 | 2014-12-17 | Fluorescent dyes, labeled conjugates and analytical methods |
US15/187,543 US20160291029A1 (en) | 2013-12-23 | 2016-06-20 | Novel Fluorescent Dyes, Labeled Conjugates and Analytical Methods |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/573,451 Division US9372194B2 (en) | 2013-12-23 | 2014-12-17 | Fluorescent dyes, labeled conjugates and analytical methods |
Publications (1)
Publication Number | Publication Date |
---|---|
US20160291029A1 true US20160291029A1 (en) | 2016-10-06 |
Family
ID=53399737
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/573,451 Active US9372194B2 (en) | 2013-12-23 | 2014-12-17 | Fluorescent dyes, labeled conjugates and analytical methods |
US15/187,543 Abandoned US20160291029A1 (en) | 2013-12-23 | 2016-06-20 | Novel Fluorescent Dyes, Labeled Conjugates and Analytical Methods |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/573,451 Active US9372194B2 (en) | 2013-12-23 | 2014-12-17 | Fluorescent dyes, labeled conjugates and analytical methods |
Country Status (1)
Country | Link |
---|---|
US (2) | US9372194B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108658893A (en) * | 2018-06-08 | 2018-10-16 | 三峡大学 | A kind of fluorescent molecular probe compound, preparation method and the application in detection L-cysteine |
CN111337465B (en) * | 2020-03-06 | 2023-04-14 | 齐鲁工业大学 | Solid-state fluorescence anti-counterfeiting method based on reversible response of amine steam |
CN114685417B (en) * | 2020-12-31 | 2023-06-27 | 菲鹏生物股份有限公司 | Organic matter for improving luminous intensity of alkaline phosphatase substrate, preparation method thereof and luminous agent for improving luminous intensity |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4039553A (en) * | 1974-02-22 | 1977-08-02 | Gaf Corporation | Certain 2(2'-hydroxyphenyl)benzothiazolo derivatives |
US4711955A (en) | 1981-04-17 | 1987-12-08 | Yale University | Modified nucleotides and methods of preparing and using same |
DE3525689C1 (en) * | 1985-07-18 | 1986-10-30 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Method and device for operating a dye laser working with a proton transfer reaction |
US5047519A (en) | 1986-07-02 | 1991-09-10 | E. I. Du Pont De Nemours And Company | Alkynylamino-nucleotides |
WO1990000618A1 (en) | 1988-07-08 | 1990-01-25 | Jbl Scientific, Inc. | Preparation and use of fluorescent benzothiazole derivatives |
US5316906A (en) * | 1991-08-23 | 1994-05-31 | Molecular Probes, Inc. | Enzymatic analysis using substrates that yield fluorescent precipitates |
US5587112A (en) | 1994-09-02 | 1996-12-24 | Philadelphia College Of Pharmacy And Science | Benzazole compounds with ESIPT fluorescence |
US5696157A (en) | 1996-11-15 | 1997-12-09 | Molecular Probes, Inc. | Sulfonated derivatives of 7-aminocoumarin |
AU4976699A (en) | 1998-07-10 | 2000-02-01 | Chromagen, Inc. | Novel fluorogenic substrates for hydrolytic enzymes |
WO2007053837A1 (en) * | 2005-10-31 | 2007-05-10 | Invitrogen Corporation | An immunosorbent assay support and method of use |
US9229007B2 (en) * | 2011-08-03 | 2016-01-05 | Portland State University | Fluorescence detection of cysteine and homocysteine |
-
2014
- 2014-12-17 US US14/573,451 patent/US9372194B2/en active Active
-
2016
- 2016-06-20 US US15/187,543 patent/US20160291029A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20150177255A1 (en) | 2015-06-25 |
US9372194B2 (en) | 2016-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7611909B1 (en) | Near infrared chemiluminescent acridinium compounds and uses thereof | |
CA1340070C (en) | Methods of using chemiluminescent 1,2-dioxetanes | |
US6322727B1 (en) | Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes | |
Lou et al. | A new turn-on chemosensor for bio-thiols based on the nanoaggregates of a tetraphenylethene-coumarin fluorophore | |
CA2118891A1 (en) | Long emission wavelength chemiluminescent compounds and their use in test assays | |
US20180299456A1 (en) | In Situ Chemiluminescent Substrates and Assays | |
AU622904B2 (en) | Enzyme activity determinations method characterized by the using of substrates whose fluorescent properties differs those of the converted products | |
US20120208223A1 (en) | Fluorescence resonance energy transfer enzyme substrates | |
US20220010356A1 (en) | Flash and Glow 1,2-Dioxetanes | |
US9372194B2 (en) | Fluorescent dyes, labeled conjugates and analytical methods | |
US9340821B2 (en) | Specific fluorescent probe based on albumin pseudo-esterase hydrolysis reaction and use thereof | |
JP2997506B2 (en) | Fluorogenic compounds and uses thereof | |
US20070184491A1 (en) | Dendritic chemiluminescent substrates | |
EP0297303A2 (en) | Fluorophores for encapsulation into liposomes | |
Zhang et al. | A near-infrared fluorescent probe for the ratiometric detection and living cell imaging of β-galactosidase | |
JP2005509859A (en) | Tag-labeled particulate composition and method | |
Li et al. | Biosensor of alkaline phosphatase based on non-fluorescent FRET of Eu 3+-doped oxide nanoparticles and phosphorylated peptide labeled with cyanine dye | |
EP0617288B1 (en) | Long emission wavelength chemiluminescent compounds and their use in test assays | |
JP2001510190A (en) | Fluorescent dibenzazole derivatives and related methods | |
US20110117571A1 (en) | Transporter assay | |
US20050239073A1 (en) | Fluorescent entity comprising a fluorophore covalently attached to at least one oligonucleotide and comprising at least one functional group, and uses thereof | |
US20050019778A1 (en) | Sequential generation of multiple chemiluminescent signals on solid supports | |
JP4237640B2 (en) | Cell growth, induction and lysis in antibody-coated microplates for use in ELISA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |